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The illicit drug market and associated crime
have a corrosive impact on Irish public life and
society – whether in terms of the high-profile
killing of rivals in the internecine world of
Dublin drug gangs, the fear and intimidation of
the impoverished communities within which
they mostly ply their trade or the petty thefts
and robberies committed by drug users to
support their addiction. Because of the huge
profits which can be derived from the illicit
drug market and the increasing public demand
for illicit substances, initiatives aimed at
deterring criminal organisations or individual
criminals from involvement in drug trafficking
face major challenges. Drug law enforcement
activities may have contributed to the relative
containment of illicit drug use and the
authorities have had some success in disrupting
drug markets and dismantling organised crime groups. However, there is little
evidence in Ireland or internationally that such strategies have halted the
expansion of the illicit drug market or reduced the criminal activities surrounding it
for any sustained period of time.1
(continued on page 2)
Drugs and crime in Ireland
Green Paper on the Role of Civil Society in
Drugs Policy in the European Union
The European Commission has published a Green Paper on the Role of Civil Society
in Drugs Policy in the European Union (COM (2006) 316 Final). The Green Paper
explores ways to involve civil society in the planning and implementation of EU
drugs policy. Voluntary and community organisations in member states, including
Ireland, are invited to give their opinions and experiences. 
The Green Paper was developed on foot of a conference held in Brussels in January,
attended by over 140 participants representing European NGO networks, including
voluntary organisations in 16 member states, four accession and candidate
countries, and Norway. This conference explored the options and highlighted
issues with regard to the involvement of civil society in the planning and
implementation of EU drugs policy.
The Green Paper was published on 26 June, which was International Day against
Drug Abuse and Illicit Trafficking, and the consultation period will run until the end
of September 2006. The Green Paper and further information regarding the
consultation can be found at http://europa.eu
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Drugs and crime in Ireland,2 the third title in the Drug Misuse Research Division’s Overview series,
was published in May 2006. The purpose of this Overview was to compile and analyse existing
data and available research on drug offences and drug-related crime, to identify gaps in
knowledge and to inform future research needs in this important area of drug policy.
The link between drugs and crime in Ireland exists simply by virtue of prevailing legislation which
defines as criminal offences the importation, manufacture, trade in and possession, other than by
prescription, of most psychoactive substances. Offences committed under this legislation are
reported in the annual reports of An Garda Síochána. Overview 3 describes and analyses trends in
drug offences since 1983. The limitations of official statistics in terms of describing the overall
crime picture have been highlighted by a number of writers in this area. These limitations,
specifically in relation to drug-related crime, are considered in the Overview.
Although the link between drugs and crime has been firmly established in the public
consciousness in Ireland, there has been little sustained examination of the precise nature of this
link. Most Irish drug users who receive sentences of imprisonment, for example, are punished, not
for drug offences per se, but for offences committed as a consequence of their drug use, such as
theft from the person, burglary, larceny or prostitution. Research studies have identified this clear
link between some forms of illicit drug use and crime – findings which are consistent throughout
criminological literature. Although the link between drug use, addiction and crime has been
established by international and Irish research, identifying the precise causative connection
between drugs and crime has been a primary preoccupation of many writers in this area. For the
purpose of this Overview, the available research evidence is reviewed using four explanatory causal
models: the psycho-pharmacological model, which identifies the drugs–crime link as arising as a
result of the intoxicating effect of the drugs themselves; the economic-compulsive model, which
assumes that drug users need to generate illicit income from crime to support their drug habit;
the systemic model, which explains drug-related crime as resulting from activities associated with
the illegal drug market; and the common-cause model, which suggests that there is no direct
causal link between drugs and crime but that both drug use and offending behaviour are related
to other factors, including socio-economic deprivation.
Another area which is considered in Overview 3 is one which is gaining increased attention in
Ireland and throughout the European Union – the link between illicit drug use and driving
offences. 
Among the key findings are:
Drug offences
■ Drug possession offences account for most drug offences recorded. In 2004, prosecutions for
simple possession made up 69 per cent of the total number of prosecutions, while supply
offences accounted for 22 per cent of the total.
■ Cannabis-related prosecutions have consistently formed the vast majority of all drug-related
offences prosecuted.
Drugs and driving
■ The typical profile of the apprehended and tested driver found to be under the influence of
drugs is that of a young male, driving in an urban area, with low or zero alcohol level, with a
specimen provided between the hours of 6 am and 9 pm and with a presence of
cannabinoids.
■ The difficulty of producing a reliable roadside sample-testing device remains an issue in this
area.
Drugs and crime: psycho-pharmacological links
■ With regard to the psycho-pharmacological connection between drug use and violent crime,
there is overwhelming evidence from the international literature of a connection between
alcohol consumption and violence.
■ International evidence of a pharmacological link between illicit drug use and violent crime is
inconclusive.
Drugs and economically-motivated crime
■ That there is an economic motivation to commit crime to purchase drugs has been
supported by Irish research. This manifests itself in an increase in such crimes following
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addiction and the reduction of such crimes
following participation in closely supervised
and well-resourced drug treatment
programmes. A number of studies of
imprisoned drug users also highlight such
links.
■ It has been suggested that a 29 per cent
reduction in recorded crime in Ireland
between 1995 and 1999 might be partially
explained by the increased availability of
methadone maintenance programmes
throughout the Dublin area during that
period.
Drugs and systemic crime
■ Local studies have highlighted the association
of local drug markets with significant levels of
community disturbance and anti-social
behaviour.
■ The operation of local drug markets can
engender significant apprehension and a
reluctance among local residents to
co-operate with law enforcement initiatives
because of fear of reprisal from drug dealers.
■ The association of drugs and violent crime
with systemic aspects of the drug trade is
borne out by the increasing evidence of
drug-related gangland murders.
Drug-related crime and gender 
■ A 1999 study of female drug users working in
the sex industry found that they differed from
non-drug-using women in the same industry
in that their primary motivation was to feed
their drug habit. The study also found that
such women tended to be younger and to
have the least favourable health risk profile of
all women working in prostitution.
■ A 2001 study of drug-using prison inmates
referred to them as ‘reluctant criminals’, in
that they engaged in crimes which they
perceived involved the lowest risk of arrest.
Common-cause model
■ With regard to the drugs–crime link, studies
of drug users have found them typically to be
single, aged between 14 and 30, male, urban,
often still living in the parental home, from
large and often broken families, having left
school before the legal minimum age of 16,
with high levels of unemployment, with their
best ever job being in the lowest
socio-economic class, with a high number of
criminal convictions and high rates of
recidivism, with a history of family members
being in prison, and a profile of extreme
social disadvantage characterised by being
from areas with a high proportion of local
authority housing and often by the
prevalence of opiate drug use and high levels
of long-term unemployment.
The Overview makes a number of
recommendations in relation to data limitations
and future research in this area. These include the
following:
Data limitations
■ In order to enhance our understanding of the
way in which drug laws are enforced and the
amount of resources being used in this area,
data should be compiled on the number of
drug-related ‘stop and search’ operations and
the number of drug-related arrests which take
place.
■ Crime statistics should be compiled and
reported as close to the local level as possible. 
Drugs and crime
Irish research in this area remains limited both in
focus and in quantity. Future research needs to
begin from a broader theoretical framework, one
which acknowledges the complexity of the
relationship between drug use and crime.
■ Research should investigate the pathways and
factors which encourage some drug users into
further drug use and offending behaviour.
■ Research is urgently needed on the
relationship between alcohol and violent
crime.
■ Given the evidence in Ireland and elsewhere
of the positive connections between drug
treatment and a reduction in offending
behaviour, further research should be
conducted on drug treatment programmes
and among drug users in receipt of treatment
to ascertain best practice in this area, and the
obstacles to progress.
■ Research is required on the relation between
drug use, drug-related crime and gender.
The question as to the link between drugs and
crime is of more than mere academic relevance.
Different conceptions of the link determine the way
in which society responds to drug users and also
inform debates about drug legislation, crime
prevention, drug treatment and law enforcement.
The aim of this Overview is to review and analyse
the available evidence on drugs and crime in
Ireland so as to inform the development of
effective responses which can contribute to the
reduction of drug-related crime. (Johnny Connolly)
1. Stevens A, Trace M and Bewley-Taylor D (2005)
Reducing drug-related crime: an overview of the
global evidence. Oxford: The Beckley Foundation
Drug Policy Programme.
www.internationaldrugpolicy.net/
2. Connolly J (2006) Drugs and crime in Ireland.
Overview 3. Dublin: Health Research Board. 
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Drugs and crime in Ireland (continued)
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The National Economic and Social Forum (NESF)
recently published a report offering practical
recommendations to help create opportunities for
vulnerable people in accessing training, education
and better quality jobs in the labour market.1
The report states that ‘labour market vulnerability is
not an aberration or a left-over from the early 1990s
– rather it continues to be generated today, even in a
tight labour market’ (p. X). Four key policy arenas
where barriers interact to produce vulnerability are
identified: economic, social, labour market and
personal. The report identifies people with drug and
alcohol dependencies as one of the marginalised
groups particularly prone to experiencing labour
market vulnerability on the basis that they face
employment barriers such as poor education levels,
low skills, inconsistent job histories and in some cases
criminal records. In addition, the report states that
there is a lack of employment support mechanisms
to assist their progression. 
There is no mechanism currently available that
systematically collects data on unemployment levels
among individuals with substance misuse issues.
However, we do have some information from the
National Drug Treatment Reporting System (NDTRS)
that indicates employment levels among individuals
reporting for treatment for problematic drug use.
According to Long et al.,2 the latest information
suggests that employment levels among treated drug
users aged 16–64 are much lower than those in the
general population. 
The 1996 report of the Ministerial Task Force on
measures to reduce the demand for drugs,3 the
National Drugs Strategy 2001–2008,4 and the
Mid-Term Review of the National Drugs Strategy
20055 all highlight the need to link labour market
training with drug treatment options. Since 1997/98,
FÁS, Ireland’s Training and Employment Authority,
has been responsible for providing the bulk of labour
market training for individuals in treatment for their
drug use through the Community Employment (CE)
scheme. However, a recent review of this training
highlighted the many difficulties involved in
progressing individuals towards labour market
employment.6 The review reported that, for a lot of
individuals engaged in labour market training
through the CE scheme, the issue of progression
highlighted a fundamental contradiction, as what
was in essence a labour market mechanism was
being used to achieve rehabilitative objectives,
sometimes at the most rudimentary level. For
example, the review found that ‘much activity
centres on defined needs around literacy, numeracy
and basic life skills. Many participants report
commencing CE having only recently emerged from
periods of profound chaos in their lives’ (p. 42). 
The NESF report also highlights the key role that
early school leaving plays in exposing marginalised
groups such as drug users to labour market
vulnerability. Drawing on a report by the European
Commission, it states that the rate of early school
leaving in Ireland remains above the EU average.
Data from the NDTRS indicate that, between 1998
and 2002 inclusive, an average of 26% of all cases
being treated for problematic drug misuse in Ireland
reported leaving school before the age of 15.2
The NESF report recommends an approach that can
be used to address this vulnerability and progress
individuals in training towards labour market
participation. However, as identified in the review of
FÁS involvement with drug users, not all individuals
can engage with labour market training at the same
level. Some require longer periods to adjust to the
demands of a structured intervention, and it is
questionable whether the FÁS CE model of
vocational training is suitable to the needs of this
group. However, for those who can engage with
specific training and education modules, the NESF
report provides a framework that incorporates an
appreciation of the interacting factors that increase
labour market vulnerability and highlights measures
to improve the pathway of progression to the labour
market. These include: 
■ locally based, integrated and inter-agency
approaches
■ client involvement in policy development and
strategic planning
■ individual training plans and one-to-one
assessment and support 
■ input tailored to the educational and training
needs and interests of the client
The report also recommends that service providers
seek to match the skills and training needs of clients
to the skills and job requirements of the labour
market. In essence, this report provides a welcome
opportunity for policy makers and drug treatment
and reintegration service providers to consider ways
of increasing progression opportunities for those
individuals that are engaged with drug treatment
services and are presenting for engagement in labour
market training initiatives. (Martin Keane)
1. NESF (2006) Creating a more inclusive labour
market. Report 33 Dublin: National Economic and
Social Forum. 
2. Long J, Lynn E and Kelly F (2005) Trends in treated
problem drug use in Ireland, 1998 to 2002.
Occasional Paper No. 17. Dublin: Health Research
Board.
3. Ministerial Task Force (1996) First report of the
Ministerial Task Force on measures to reduce the
demand for drugs. Dublin: Stationery Office. 
4. Department of Tourism, Sport and Recreation
(2001) Building on experience: National Drugs
Strategy 2001–2008. Dublin: Stationery Office.
5. Steering group for the mid-term review of the
National Drugs Strategy (2005) Mid-term review of
the National Drugs Strategy 2001–2008. Dublin:
Department of Community, Rural and Gaeltacht
Affairs. 
6. Bruce A (2004) FÁS Community Employment
schemes for local drugs task force areas. Dublin:
Unpublished report for FÁS.
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Drug use and labour market vulnerability
As part of its strategy on drugs and alcohol, the
Gaelic Athletic Association (GAA) recently
appointed a national co-ordinator for its Alcohol
and Substance Abuse Prevention (ASAP)
programme. Brendan Murphy, formerly Regional
Drugs Training Officer with the HSE Western Area,
took up his new position in November 2005. He
spoke recently to Drugnet Ireland about his work in
implementing the GAA’s strategy and the
development of the organisation’s policy in this
area.
In June 2004 the GAA Task Force into Alcohol and
Substance Abuse, following consultation with
members of the association, health professionals
and others, published a report1 of its findings and
recommended that the GAA should actively work
towards reducing the level of drug and problem
alcohol use in Irish society. The report
recommended a comprehensive education
programme on drugs and alcohol with an
emphasis on young members. It also
recommended the creation of a code of conduct
for the serving of alcohol in clubs and at GAA
functions and the development of guidelines in
relation to advertising or sponsorship involving the
drinks industry. 
The Task Force, chaired by Galway All-Ireland-
winning captain Joe Connolly, recognised the
shortcomings in existing prevention programmes
and its deliberations were informed by a health
promotion approach to problem drug and alcohol
use. It saw clearly the need to develop a broad
programme which all members could contribute to
and have a role in shaping. A major task facing the
new co-ordinator of the ASAP programme is to set
up the structure through which the GAA’s policy
will be implemented. This structure will comprise
32 county officers, each of whom will work with,
but will not be part of, the association’s county
boards. All county officers will receive training in
facilitating meetings and other skills. So far, six
county officers have been appointed.
The county officers will assist Mr Murphy in
selecting club officers and eventually there will be
an officer attached to each of the country’s 2,500
GAA clubs. Each officer will co-ordinate the
development of the club’s own drug and alcohol
policy. The policy will be based on a common
template but each club will have considerable
autonomy in deciding what policies are
appropriate to its particular circumstances and local
conditions. An important element of club policy on
alcohol and drugs will be an outline of how the
club communicates on this issue with the Garda
and with local HSE health promotion and drug and
alcohol units. Each individual club policy must also
outline appropriate actions in the areas of
prevention, education (for both adults and
juveniles) and responses to incidents. 
While these structures are being put in place the
GAA will be working on practical prevention and
education initiatives. These will include delivering
video segments to the mobile phones of young
members, carrying a series of messages from
well-known players from the members’ own county
team. This initiative anticipates more extensive use
of 3G mobile phone technology.
The administrative structure of the GAA has served
it well throughout its 120-year history. It has a
presence in every parish in the country. Its
development and administration and the
promotion of its values depend on committed and
energetic voluntary effort in all its 2,500 clubs
throughout the country. This structure and outlook
allow it to take on a very ambitious programme of
prevention and education. The ASAP programme
plans to establish a network to collect baseline
data, using existing models such as the ESPAD or
HBSC surveys, and monitor trends over the course
of the programme. This could provide a very
valuable, and possibly unique, insight into the
effectiveness of this type of prevention and
education programme. (Brian Galvin)
1. GAA Task Force into Alcohol and Substance Use
(2004) A report by the GAA Task Force into Alcohol
and Substance Use. Dublin: Gaelic Athletic
Association.
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GAA initiative on alcohol and substance
abuse
Mr Brendan Murphy, national co-ordinator of the
GAA’s Alcohol and Substance Abuse Prevention
(ASAP) programme.
In March 2006 the National Advisory Committee
on Drugs (NACD) in Ireland and the Drug and
Alcohol Information and Research Unit (DAIRU) in
Northern Ireland published confidence intervals for
the prevalence estimates from the 2002/2003 drug
prevalence survey.1,2 This article will help explain in
non-technical terms the importance of confidence
intervals and how to interpret the recently
published figures.
The term ‘prevalence’ in the context of drug use
refers to the proportion of a population who used
a drug over a particular time period. Information
on drug use among the population is usually
gathered through surveys and prevalence is
measured by asking respondents in a sample
randomly drawn from the population to recall their
use of drugs. For example, in Ireland, the lifetime
prevalence (ever used drug in lifetime) of cannabis
for adults (15–64 years) was estimated to be
17.4% in 2002/2003. Since this estimate is based
on a sample, the true prevalence in the population
may be different.
Provided a sample is ‘representative’ of the total
population, prevalence information obtained from
it can be used to infer the prevalence in the
population with a certain degree of confidence.
The representativeness of a sample refers to the
extent to which it mirrors the population of
interest. The calculation of a confidence interval
provides us with upper and lower value limits that
contain the true value with a degree of certainty.
By convention, a 95% level of certainty is chosen
for confidence intervals in drug prevalence surveys.
For example, the recently published 95%
confidence interval for lifetime prevalence of
cannabis is reported as ranging from 16.3% to
18.4% (Table 1). Thus we can say that we are 95%
confident that the true proportion of cannabis
users in the population is in the range
16.3%–18.4%. In other words, the prevalence
could be as low as 16.3% or as high as 18.4%. 
To obtain an exact prevalence figure, the entire
population would have to be surveyed – which
would be prohibitively expensive.
Table 1 shows the lifetime, last-year and last-month
use of cannabis by adults, by region (former health
board area). While some of the regional prevalence
estimates are much higher than the national
estimate and others are lower, the confidence
intervals allow us to determine whether the
regional estimates differ significantly from the
national estimate. If the range of values for a
regional estimate did not overlap the range of
values for the national estimate, this would be
regarded as a statistically significant difference 
(i.e., the difference is unlikely to be due to chance).
For example, lifetime prevalence of cannabis in the
East Coast Area ranges from 20.8% to 28.2%,
while the national estimate ranges from 16.3% to
18.4%; thus, the East Coast Area estimate is
regarded as statistically higher than the national
estimate. 
Figures 1a to 1c show the regions that have
statistically higher or lower prevalence estimates for
cannabis use compared to the national estimate.
For lifetime use, only three regions have prevalence
estimates statistically higher than the national
estimate and five areas have statistically lower
estimates (Figure 1a). For both last-year and
last-month use, no region has an estimate
statistically higher than the national estimate
(Figures 1b and 1c). This is due to two factors: the
low number of people who used cannabis in the
last year or last month and the small number of
people in each of the regional samples.
In general, the larger the sample the narrower the
confidence intervals and the more precise we can
drugnet
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Estimating the true prevalence of drug
use in the population
Table 1   Lifetime, last-year and last-month use (%) of cannabis by adults (15–64 years)
by region (former health board area) in 2002/2003. Figures in brackets are 95%
confidence intervals.
Region (former health board) Use of cannabis
Lifetime Last year Last month
% (95% CI) % (95% CI) % (95% CI)
East Coast Area 24.5 (20.8–28.2) 6.1 (4.1–8.2) 3.8 (2.2–5.5)
Northern Area 26.9 (23.3–30.4) 7.7 (5.5–9.8) 4.5 (2.9–6.2)
South West Area 23.2 (20.1–26.3) 7.3 (5.4–9.2) 3.9 (2.5–5.3)
Midland 10.7 (7.0–14.4) 2.8 (0.8–4.7) 1.0 (0.2–3.2)
Mid-Western 10.9 (7.9–13.9) 3.0 (1.3–4.6) 1.6 (0.4–2.9)
North Eastern 17.8 (14.1–21.4) 5.2 (3.0–7.3) 1.9 (0.6–3.2)
North Western 9.3 (5.8–12.8) 2.2 (0.4–3.9) 0.2 (0.0–1.9)
South Eastern 16.8 (13.6–20.0) 5.8 (3.8–7.8) 2.1 (0.9–3.4)
Southern 11.6 (9.2–13.9) 4.4 (2.9–5.9) 2.1 (1.1–3.2)
Western 12.0 (9.1–15.0) 2.0 (0.7–3.3) 1.3 (0.3–2.3)
Ireland 17.4 (16.3–18.4) 5.0 (4.4–5.7) 2.6 (2.1–3.0)
be in estimating the true prevalence of drug use in
the population. It is good practice to provide
confidence intervals to indicate the level of
precision associated with survey estimates. (Hamish
Sinclair)
1. National Advisory Committee on Drugs and
Drug and Alcohol Information and Research Unit
(2006) Drug use in Ireland and Northern Ireland.
2002/2003 drug prevalence survey: first results
(revised) from the 2002/2003 drug prevalence
survey – Bulletin 1. Confidence Intervals. Dublin:
National Advisory Committee on Drugs.
2. National Advisory Committee on Drugs and
Drug and Alcohol Information and Research Unit
(2006) Drug use in Ireland and Northern Ireland.
2002/2003 drug prevalence survey: Health Board
(Ireland) & Health and Social Services (Northern
Ireland) results (revised) – Bulletin 2. Confidence
Intervals. Dublin: National Advisory Committee
on Drugs.
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Estimating the true prevalence of drug use (continued)
Statistically higher
prevalence than
national estimate
Neither statistically
higher nor lower
prevalence than
national estimate
Statistically lower
prevalence than
national estimate
Figure 1a   Lifetime use of cannabis by
adults (15–64 years) by region
in 2002/2003
Figure 1c   Last-month use of cannabis by
adults (15–64 years) by region
in 2002/2003
Figure 1b   Last-year use of cannabis by
adults (15–64 years) by region
in 2002/2003
This article reports on progress made so far on
actions pertinent to the association between
homelessness and substance misuse or addiction
contained in the documents Homelessness: An
Integrated Strategy (2000)1 and in Homeless
Preventative Strategy (2002).2
The Integrated Strategy identified individuals
leaving custodial and health-related institutional
care (psychiatric care and care for vulnerable
young people) as a group at risk of becoming
homeless. Recent research in Ireland has
demonstrated a strong association between drug
misuse and homelessness among individuals in
custody.3 On the other hand, there is a lack of Irish
research on the association between drug misuse,
homelessness and people with experience of
institutional health-related care, despite the fact
that research into the homeless population in
Ireland has reported drug misuse, mental health
issues and being in care as factors associated with
becoming and remaining homeless.4,5
Actions 9 and 11 of the 2000 strategy require
statutory and voluntary agencies to provide a mix
of suitable emergency accommodation for
homeless women, couples, families and homeless
persons with substance addictions, as well as
high-support hostels for the last group. The recent
review of the implementation of the Integrated and
Preventative Strategies6 reports that ‘the supply,
range and quality of emergency accommodation
available … have increased significantly over the
last five years’ (p. 31). However, while this may be
the case for most of the groups included under
Actions 9 and 11, there is no specific information
in this review to show that emergency
accommodation has been made more available or
more accessible to homeless individuals engaged in
drug misuse. Indeed, recent research has shown
that such individuals (a) continue to experience
barriers to accessing emergency accommodation
and (b) are resistant to using emergency
accommodation for fear of escalating their drug
use.3,7 Research by Courtney8 found that, although
there was a reduction in the number of individuals
sleeping rough in the Dublin area and the number
of referrals of individuals with low-support needs
had decreased, there was an increase in referrals of
those with multiple needs, usually involving
substance abuse and physical or mental health
problems, which can result in chaotic or
challenging behaviour. The lack of explicit policies
on dealing with drug users and drug use among
providers of homeless services is primarily
responsible for these issues of accessibility to
emergency accommodation,7 with many services
operating a policy of excluding active drug users.
The review acknowledges that dedicated hostels in
the form of night shelters have been introduced in
the Dublin area, primarily targeting the needs of
individuals suffering alcohol addiction. But the
review does not make explicit the availability or
accessibility of these hostels for individuals
engaged in drug misuse.6
An area where there has been welcome progress is
the accommodation needs of ex-offenders. The
Homeless Preventative Strategy, which developed
from Action I in the Integrated Strategy, identified
ex-offenders as being at risk of homelessness on
leaving institutional custodial care. The review of
the implementation of both strategies6 reports that
a specialist unit, the Homeless Offenders Strategy
Team (HOST), has been established by the
Probation and Welfare Service (PWS) to assist
ex-offenders find accommodation. In addition, the
Prison Service and the PWS are engaged in
building and operating transitional housing units
for ex-offenders; 34 such places have been
developed. This is a welcome development, as
research consistently shows that being homeless on
release from custodial institutions exposes
individuals to a high risk of relapsing into drug
use.9,10
As part of the review of the homeless strategies6 33
homeless service users were interviewed between
March and May 2005. Family breakdown and
associated problems of alcohol and substance
abuse were cited as the primary reasons for
becoming homeless in the first instance. Many of
the interviewees reported that they had relapsed
when accommodated in homeless hostels after
having been drug or alcohol free for a considerable
period of time. A number of interviewees reported
that they had to wait for six to nine months to join
a methadone programme. This research again
emphasises the important task facing statutory and
voluntary service providers in tackling the strong
association between drug misuse and
homelessness. Despite the measures progressed so
far, it would appear that major gaps in service
provision remain, particularly in relation to
individuals with multiple needs, including active
drug users. (Martin Keane)
1. Department of the Environment and Local
Government (2000) Homelessness: An Integrated
Strategy. Dublin: Department of the
Environment and Local Government.
2. Departments of Education, Environment, and
Health and Children (2002) Homeless
Preventative Strategy. Dublin: Stationery Office.
3. Seymour M and Costello L (2005) A study of the
number, profile and progression routes of homeless
people before the court and in custody. Dublin:
Probation and Welfare Service. 
4. Smith M, McGee H and Shannon W (2001) 
One hundred homeless women: health status and
health service use of homeless women and their
children in Dublin. Dublin: Royal College of
Homelessness and drug misuse: a
continuing challenge for service providers
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Surgeons in Ireland and the Children’s Research
Centre, Trinity College Dublin. 
5. Feeney A, McGee H, Holohan T and Shannon W
(2000) The health of hostel-dwelling men in
Dublin: perceived health status, lifestyle and health
care utilisation of homeless men in south inner city
Dublin hostels. Dublin: Royal College of Surgeons
in Ireland and Eastern Health Board.
6. Fitzpatrick Associates Economic Consultants
(2006) Review of the implementation of the
government’s Integrated and Preventative
Homeless Strategies. Report submitted by to the
Minister for Housing and Urban Renewal.
Dublin: Stationery Office.
7. Lawless M and Corr C (2005) Drug use among
the homeless population in Ireland. Dublin:
Merchants Quay Ireland.
8. Courtney R (2005) Review of temporary
accommodation. Dublin: Homeless Agency.
9. Hickey C (2002) Crime and homelessness. Dublin:
Focus Ireland and PACE.
10. O’Loingsigh G (2004) Getting out, staying out:
the experiences of prisoners upon release. Dublin:
Community Technical Aid.
Homelessness and drug misuse (continued)
The report of the Expert Group on Mental Health
Policy A Vision for Change was published on 24
January 2006.1 The report details a comprehensive
model of mental health services in Ireland. This
model will emphasise the development of mental
health services in the community over the next five
to ten years. 
According to the expert group, ‘individuals [adults
and children] whose primary problem is substance
abuse and who do not have [other] mental health
problems will not fall within the remit of mental
health services’. In a departure from the
international classification system, substance abuse
(dependence) will no longer be included among
the categories of mental health problems in
Ireland. 
According to the report, the major responsibility
for the care of those with substance abuse
(dependence) lies outside the mental health
services, and rests with separate services that have
their own funding structure within Primary,
Community and Continuing Care (PCCC) in the
Health Service Executive. Historically, such funding
was allocated for the care of those with drug
dependence rather than alcohol dependence. The
report does not clarify how the mental health
services will reassign to the PCC function the staff
and finance currently used to address alcohol
dependence in the mental health services. 
The expert group states that beds in acute
psychiatric facilities ‘should not be used for routine
detoxification, which should be done on an
outpatient basis’, and goes on to state that ‘more
complex detoxification should take place in acute
general hospital facilities’. The policy report does
not give the rationale behind this approach, nor
does it indicate who will supervise such
detoxifications in the general hospital.
In relation to the issue of substance abuse
(dependence), the report recommends that: 
■ Mental health services for both adults and
children will be responsible for providing
mental health services to individuals who
have another mental illness in addition to
their substance abuse (dependence). 
■ General adult community mental health
teams will care for adults with substance
abuse and another mental health problem
when the mental health problem is the
primary problem. 
■ Specialist substance abuse mental health
teams for adults with complex severe
substance abuse and mental disorders will be
established. These specialist teams should
establish clear links with local community
mental health services, and clarify pathways in
and out of their services. 
■ Two additional specialist substance abuse
teams for children with substance abuse
(dependence) and mental disorders should be
established outside Dublin. 
■ A post for a national co-ordinator should be
established in the PCCC function of the
Health Service Executive. According to the
policy document, the co-ordinator should
develop standards for the delivery of
interventions to address alcohol and drug
abuse (dependence) in Ireland and establish
how such interventions will be linked to
mental health. 
(Jean Long)
1. Expert Group on Mental Health Policy (2006) 
A Vision for Change: Report of the Expert Group on
Mental Health Policy. Dublin: Stationery Office.
New mental health policy distances its
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In April 2006, Alcohol Action Ireland published the
findings from an omnibus survey by Millward
Brown IMS of public attitudes to alcohol
consumption and to possible policy changes
required to reduce alcohol-related harm.1 Using a
quota-based sampling method, 1,093 adults aged
18 years or over were interviewed between 20
October and 3 November 2005. The sample was
quota-controlled by age, gender, social class and
geographical region to ensure representation of the
adult population living in Ireland.
The main findings of the survey are discussed
below.
Alcohol-related harm
Two thirds (66%) of all respondents personally
knew someone who had a problem with alcohol
consumption, and over half (57%) had been
concerned about someone’s alcohol use, which
suggests that these people had a closer relationship
with the person with the problem. When
respondents were asked if they or anyone close to
them had experienced an injury, harassment or
intimidation caused by their own or someone else’s
use of alcohol, 44% answered ‘Yes’.
Given this high level of perceived or experienced
harm, it is not surprising that a majority (82%) of
respondents believed that the current level of
alcohol consumption in Ireland was a problem and
that a similar majority (85%) believed that our
cultural attitude towards drinking alcohol and the
behaviour that goes with it should change. These
beliefs were more prevalent among women than
men. Just over half (51%) of all respondents
believed that the government was not doing
enough to address the problems caused by alcohol
use; 23% were undecided on this question. The
response was generally consistent across gender
and age groups.
Taxation and drink driving
While taxation increases are never popular, just
over half of the respondents (54%) stated they
would accept an increase in excise duty or tax on
alcohol if it was ‘specifically put towards an
initiative that led to a reduction in alcohol-related
harm’. A majority (87%) of respondents were in
favour of full nationwide introduction of random
breath testing to detect drink-drivers. The survey
report notes that support for random breath
testing was strong (84%) even among rural
respondents who generally have fewer transport
options when socialising outside the home.
However, nearly three-quarters (72%) of all
respondents did not believe that the gardaí have
enough resources to enforce the current law in
relation to drink-driving.
Advertising and sponsorship
While support for an outright ban on all forms of
alcohol advertising was low (44% in favour), a
much larger proportion (72%) wished to see
alcohol advertising permitted only after 9.00 pm,
when children’s peak television-viewing time was
over. Only 39% of respondents agreed that
sponsorship of sports by the alcohol industry
should be brought to an end; 35% opposed the
idea; and 26% were undecided. More women than
men agreed with a ban on sport sponsorship (45%
compared to 33%).
Alcohol availability
Only one-third (33%) of respondents believed that
the gardaí have sufficient resources to enforce the
current law governing pub opening hours. A
majority (71%) believed that allowing alcohol to
be sold via the phone or internet would make it
easier for under-18s to buy alcohol. Again, a large
majority (74%) of respondents did not believe that
the gardaí had enough resources to ensure that the
law governing sales of alcohol to minors was
enforced.
Treatment interventions
A majority (76%) of respondents were in favour of
health and other professionals asking questions to
identify problem drinking at an early stage in
settings where a person showed signs of alcohol-
related harm. Only a small proportion (3%) where
opposed to this proposal, while 21% were neutral
on the issue. Repeated attendance at accident and
emergency (A&E) departments by a person under
the influence of alcohol can be an indicator of an
alcohol-related problem. Again, a majority (61%)
of respondents were in favour of A&E departments
having a specific service in place to refer patients
with persistent alcohol-related problems. It is
interesting to note that over one-third (37%) did
not feel that such a service should be the
responsibility of the A&E department.
Alcohol agency
A majority of respondents (85%) believed that the
government should set up an agency with specific
responsibility for tackling alcohol-related problems.
The findings of the survey suggest that there is
widespread public support for measures such as
random breath testing, identifying problem
drinking at an early stage and restricting alcohol
advertising to after 9.00 pm. Less popular, but still
supported by a majority of the public, are
measures such as an A&E referral service for
patients with persistent alcohol-related problems
and an increase in excise duty or tax on alcohol.
There was also a general belief that the gardaí did
not have sufficient resources to enforce the law
regarding drink-driving, opening hours and the
sale of alcohol to minors. (Hamish Sinclair)
1. Alcohol Action Ireland (2006) Alcohol in Ireland:
time for action. A survey of Irish attitudes. Dublin:
Alcohol Action Ireland.
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On 3 May 2006 the Heath Service Executive (HSE)
organised a workshop on cocaine, bringing together
HSE staff and representation from the voluntary,
community and statutory sectors. Opening the
workshop, Alice O’Flynn, National Care Group
Manager for Social Inclusion, stated that the
growing problem of cocaine was an important issue
for the HSE. An overview of the workshop was given
by Cathal Morgan, HSE National Drugs Strategy
manager. The aims of the workshop were to:
■ Provide an overview of prevalence in relation
to cocaine (including crack) use.
■ Identify current key responses in relation to
cocaine.
■ Identify models of best practice based on
research evidence.
■ Discuss future responses to cocaine.
The workshop began with a series of presentations
followed by group work.
Dr Eamon Keenan, clinical director of the HSE South
Western Area Addiction Services, presented data on
the prevalence of cocaine use in the general
population and on treatment for problem cocaine
use from 1998 to 2003. The number of treated
cases reporting problem cocaine use increased
considerably over this period. Of note, a substantial
and increasing number of treated cases reported
cocaine as an additional problem drug. Dr Keenan
highlighted the need for more timely information in
respect of both prevalence and treatment figures.
Dr Richard Maguire, principal biochemist at the
Drug Treatment Centre Board, reported a rise in the
number of methadone clients testing positive for
cocaine use between 1998 and 2005. His findings
mirrored the trend in cocaine use observed in the
treatment data on additional problem drugs. 
Detective Superintendent Barry O’Brien, Garda
National Drugs Unit, presented the most recent data
on cocaine and diamorphine (mainly heroin)
offences and seizures. He reported that cocaine
offences (as a proportion of all drug offences) had
increased almost sevenfold between 2000 and
2005, from 2% to 13%, while diamorphine offences
had remained high but the trend was relatively
stable, increasing from 9% to 11% over the same
time period. In terms of cocaine and diamorphine
seizures, similar trends were observed. Cocaine was
now being seized in many towns throughout the
country.
Tony Geoghegan, director of Merchants Quay
Ireland, gave a presentation on the treatment of
cocaine from the voluntary drug treatment
perspective and reported an increase in the number
of cocaine users attending harm-reduction services. 
Anna Quigley, manager of CityWide, presented the
current effects of cocaine use on communities in
Dublin. She said that the cocaine market is based in
pubs or operates through mobile phone contact.
According to Ms Quigley, alcohol and cocaine use
are closely associated. She highlighted a number of
social and economic consequences of cocaine use,
such as debt, violence and insecurity. 
Dr Brion Sweeney, clinical director of the HSE
Northern Area Addiction Services, presented the
evidence base for the treatment of problem cocaine
use and stated that cogitative behavioural therapy in
conjunction with other interventions was the most
successful form of treatment. He went on to state
that prompt, accessible and tailored interventions
increased the effectiveness of such treatment. He
pointed out that the evidence indicated that the use
of medication in the treatment of cocaine
dependence had little effect, but that new
developments were expected in this area.
Following the presentations, participants were
divided into small groups and asked to respond to a
series of questions. Each group was asked to
prioritise four key principles that they considered
important in responding to the issue of cocaine. In
addition, each group was asked to suggest ideas for
a follow-up to the current workshop. 
A number of common themes came out of the
feedback from the different groups. Among these
were:
■ The response to the growing cocaine problem
requires a co-ordinated approach, involving
statutory, voluntary and community groups.
■ The perception of cocaine as a ‘clean and safe’
drug needs to be changed.
■ The availability of cocaine in pubs tends to link
the drug with alcohol and gives it an
‘acceptability’ which needs to be addressed.
■ Appropriate outreach services need to be
developed to bring difficult-to-reach cocaine
users into contact with treatment services.
■ Approaches to treatment need to be timely
and evidence based.
■ Existing treatment services need to be
enhanced, rather than new services specifically
for cocaine created.
■ More timely information is required to
monitor, at an early stage, the emergence of
new drugs and the changing patterns of
current drug use.
Acknowledging the success of this event,
participants felt that a follow-up workshop should
be organised later in the year to review progress. At
the close of the meeting, Cathal Morgan thanked
participants and indicated that the HSE would
produce a report on the day’s proceedings and that
action would be taken on the basis of the workshop
outcomes. (Hamish Sinclair and Jean Long)
Health Service Executive facilitates
workshop on cocaine
Recent research published by the Equality
Authority1 highlights the ways in which a selection
of teenagers believe they are negatively perceived
and treated by adults across Irish society. The
report is based on focus group discussions with
some 90 teenagers during May and June 2005 and
includes the views of young asylum seekers,
travellers, people with disabilities and lesbian, gay,
bisexual and transgender youth. Contact with the
young people was facilitated through the National
Youth Council of Ireland (NYCI). The report also
includes findings from a case study of stereotyping
of young people in the Irish media.
The media
The media were most commonly identified by the
focus groups as creators of negative stereotypical
images of young people by constantly associating
them with crime, deviance, disorder and drug and
alcohol problems. Empirical findings from the case
study of the Irish media supported this view but
also highlighted the gender differences in media
representations, with young men often portrayed
in criminal and deviant terms and young women in
terms of victimhood and vulnerability. 
The gardaí and the security industry
Evidence of poor relationships with the gardaí, and
the view that the gardaí had a poor opinion of
young people, dominated several of the focus
group discussions. However, some young people
reported that their relations with some individual
community gardaí were quite positive. Young
people reported being treated differently from
adults by security personnel in shops and shopping
centres in terms of being followed and observed.
They felt that security personnel discriminated
against them because of their age and their
clothes. 
Politicians
With very few exceptions, the young people’s
experiences and opinions of politicians and their
perceptions of politicians’ attitudes towards young
people were negative. Politicians were seen as
representing the views of the adult generation and
as dismissing young people as unimportant. Young
people felt that not having the vote until they were
aged 18 rendered them voiceless and unimportant
to the politicians. 
Teachers and school
The young people felt that they were not being
treated equally by their schools or teachers. They
gave examples of different rules about the use of
mobile phones applying to teachers and to
students in the classroom. Young people felt that
they did not have a voice in how their schools
were being run. They felt that school rules should
be negotiated between young people and the
school authorities instead of being imposed. 
The local community
Young people reported constant ‘hassle’ in public
from adults, especially when ‘hanging around’ in
groups on their local estates. They accepted that
meeting outdoors in groups made them more
visible, but explained that they had few alternative
places to meet with their peers. Recent research in
Scotland by Seaman et al.2 highlights the benefits
young people derive from congregating with their
peers; for example, the feeling of safety from being
part of the ‘gang’ as their friends often provide
them with information about the risks and safety
precautions required around certain estates. 
The importance of the peer group among
teenagers is reflected in the quantity of time they
spend ‘hanging out’ together and the importance
they place on mutual support. Recent research by
Lalor and Baird3 among a sample of adolescents in
Co Kildare revealed that a favoured activity among
respondents was ‘hanging out with friends’, with
over half the sample spending between five and
fourteen hours per week with friends. Close friends
and peers were listed as being key sources of social
support that young people turn to when they
encounter problems. 
Although the views and experiences raised by
young people in this research by the Equality
Authority cannot be generalised to the wider
population of young people, they do provide an
opportunity for youth workers, teachers, Garda
Juvenile Liaison Officers and other professionals
working with young people to reflect on their
methods of engagement. Teachers and Garda
Juvenile Liaison Officers often deliver drug
education and awareness programmes to young
people of a similar age and profile to this group.
The perception by young people that they are not
respected by such figures has implications for the
effectiveness of such programmes. It might be
more effective to train young people themselves to
deliver drug prevention programmes. This would
go some way to creating conditions of negotiation
between young people and significant adults in
society around a key issue of behavioural change in
relation to substance misuse. (Martin Keane)
1. Devlin M (2006) Inequality and the stereotyping
of young people. Dublin: The Equality Authority. 
2. Seaman P, Turner K, Hill M, Stafford A and
Walker M (2006) Parenting and children’s
resilience in disadvantaged communities. London:
National Children’s Bureau. 
3. Lalor K and Baird K (2006) Our views – Anybody
listening? Researching the views and needs of
young people in Co Kildare. Kildare: Kildare Youth
Services.
Inequality and the stereotyping of young
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drugnet
IRELAND
12
drugnet
IRELAND
13
A new strategy document published by the Irish
Prison Service (IPS) entitled ‘Keeping drugs out of
prisons’ proposes to tackle the use of illicit drugs in
Irish prisons by focusing on supply elimination and
demand reduction.1 To implement this new
strategy, the IPS recognises the need for quality
research on the extent and nature of drug misuse
within Irish prisons. In his address to the annual
conference of the Prison Officers’ Association in
Killarney on 4 May 2006 the Minister for Justice
Michael McDowell reiterated his policy of ‘zero
tolerance’ in relation to the use of drugs in
prisons.2
Despite a lack of published data, a number of
studies conducted with prisoners indicate that
there is a readily available supply of drugs in some
Irish prisons.3,4,5 Reports suggest that visits by
friends and family and the throwing of drugs over
perimeter walls are among the supply routes used
in Mountjoy prison. Another possible source of
supply is the trafficking of drugs by prison staff.
Responding to a claim by the Inspector of Prisons,
Mr Justice Dermot Kinlen,6 Minister McDowell has
confirmed that a number of prison officers are
currently under suspension and facing criminal
proceedings in relation to drug smuggling.7
Anecdotal evidence suggests that vulnerable
prisoners are pressurised into receiving drugs from
visitors or picking up packages of drugs thrown
over the perimeter wall. The new strategy
document recommends that searches after visits
should not be confined to known drug users but
should include prisoners who could be intimidated
into receiving drugs on a visit.
Current measures in place in Mountjoy prison to
prevent the supply of drugs during visits include
CCTV cameras, screened visits whereby physical
contact between prisoner and visitor is prevented
and random searches of prisoners. Prisoners are
required to nominate visitors, who must produce
identification when entering the prison, in order to
reduce the number of visitors giving false names in
an attempt to smuggle in drugs. These measures
have been included in the new IPS policy and
strategy document and are to be extended to all
prisons along with new initiatives, including a
recommendation that physical contact between
visitors and prisoners should not be permitted
unless sanctioned by the governor and that any
unscreened visits should be booked in advance. 
Mountjoy prison authorities and the Garda
Síochána operate in partnership to prevent drugs
being thrown into the prison grounds from
outside; officers patrol yard areas to intercept
packages and prevent prisoners collecting them;
and efforts are made to arrest individuals
attempting to pass drugs over the perimeter walls
from outside the prison. Cases where a prison
officer is suspected of smuggling drugs are handled
by the gardaí.
A prisoner found to be in possession of illegal
drugs is liable to a number of sanctions: evening
recreation may be withdrawn for a number of
days; future visits may be screened for a given
period of time; or remission may be curtailed. The
maximum punishment that can be applied is a loss
of 14 days’ remission and the loss of all privileges
for two months. Similar punishments apply where
a prisoner commits a drug-related offence in
prison, such as possession of a syringe, sharing a
toilet cubicle for drug use or giving a false name to
obtain medication.
Searches are a significant part of the attempt to
reduce the supply of drugs into Mountjoy prison.
Prisoners being committed to prison and those
returning from temporary release are strip-searched
to ensure they are not carrying drugs on their
person. Two random searches, where the prisoner
and his cell are searched, are conducted on each
landing within the prison every day. Prisoners are
also sometimes searched after visits. However,
prison officers do not generally search visitors.
Where a visitor is suspected of supplying drugs, the
prison will alert the gardaí who handle the matter
of searching visitors on their way into the prison.
As part of the IPS strategy, passive canine units will
be made available to all closed prisons to assist in
the detection of drugs within the prison or in the
possession of visitors.
The IPS strategy also provides for the introduction
of mandatory drug testing (MDT) by the end of
2006. This will involve 5% to 10% of prisoners
being randomly selected for drug testing each
month. A prisoner who refuses to take the test or
tests positive for drugs will incur sanctions.8
The IPS recognises that the best way to reduce the
demand for drugs in prison is by providing a range
of evidence-based treatment options. The prison
service has outlined three core tasks to support
drug treatment and rehabilitation:
1. Identifying and engaging with drug users
2. Providing treatment options
3. Ensuring continuity of treatment and care
following release. 
The core treatment options are:
■ assessment and through-care planning
■ information, education and awareness
programmes
■ opiate replacement therapies
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■ methadone detoxification and reduction
programmes
■ symptomatic treatment options
■ mental health care
■ voluntary drug testing units 
■ motivational interventions. 
A number of specialised treatment options will also
be available in designated prisons, including
cognitive behavioural therapy, the 12-step
Minnesota model, peer-support programmes and
specialised programmes to address drug misuse
and re-offending. The treatment approaches will be
adapted for prisoners with special needs, including
drug users with mental health problems or
hepatitis C. The IPS strategy states that there will
be a close link between drug treatment services
and other health care services to ensure adequate
management of mental illnesses and blood-borne
viral diseases. The IPS has no harm-reduction
strategy for those drug users who continue to use
drugs. 
At present there are no official statistics regarding
the supply of drugs in Irish prisons and no studies
have been conducted on the illicit drug market in
Irish prisons. As part of its new strategy, the IPS
aims to strengthen research in the area of drug
misuse in prisons. This research will be based on
partnership between the relevant statutory and
non-statutory bodies. Policies will include:
■ commissioning and encouraging research on
drug misuse in prisons
■ evaluating all programmes and interventions
■ making all research data available to and
liaising regularly with the relevant bodies
■ investigating systems to identify and manage
patient outcome data
■ evaluating the effectiveness of drug
interventions using intervention outcome
information.
Research will be used to inform policy makers and
service providers in implementing the IPS strategy
and to develop models of best practice. 
(Johnny Connolly, Sinead Foran and Jean Long)
1. Irish Prison Service (2006) Keeping drugs out of
prisons: drugs policy and strategy. Dublin: Irish
Prison Service.
2. Address by Minister for Justice Michael
McDowell TD to the Annual Conference of the
Prison Officers’ Association,
www.progressivedemocrats.ie/press_room/1787/
3. O’Mahony P (1997) Mountjoy prisoners: a
sociological and criminological profile. Dublin:
Department of Justice. 
4. Long J, Allwright S and Begley C (2004)
Prisoner’s views of injecting drug use and harm
reduction in Irish prisons. International Journal of
Drug Policy, 15: 139–149. 
5. Dillon L (2001) Drug use among prisoners: an
exploratory study. Dublin: Health Research Board.
6. Lally C (2006, 6 May) Five prison officers
suspected of drug smuggling. The Irish Times.
Retrieved 15 May 2006 from www.ireland.com 
7. Bracken A (2006, 6 May) McDowell confirms
suspensions. The Irish Times. Retrieved 15 May
2006 from www.ireland.com
8. For a review of mandatory drug testing, see
Connolly J (2005) Prison rules provide for
mandatory drug testing. Drugnet Ireland, 
Issue 15: 15. 
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An exploration by Corr1 of drug use among new
communities in Ireland reported that drug users
from new communities were generally unaware of
drug service provision in Ireland, and were
doubtful of the confidentiality of information held
by such services. The report recommended that
information material produced for these
communities highlight the range of services
provided in Ireland and their confidential nature. It
also recommended that the information be
translated into appropriate languages and
distributed in places drug users from new
communities were most likely to frequent. 
Merchants Quay Ireland (MQI), the largest
voluntary sector provider of homeless and drugs
services in Ireland, has taken the lead in this regard
and recently produced information leaflets in
English, Polish and Russian detailing service
provision at MQI. The leaflets contain details on
services for drug users such as needle exchange,
methadone prescribing, residential drug-free
services, and settlement and integration services
providing help with accommodation and training
and employment support. Also included are details
of the services for homeless people, including crisis
support, meals service, primary healthcare and a
women’s health programme. Opening hours and
direct-dial phone numbers specific to each service
are provided. The services are open to all
individuals experiencing drug use or homelessness.
Service providers in the drugs area wishing to avail
of these leaflets for dissemination to their clients
are invited to contact MQI for arrangements. You
may contact Niamh Randall at 01 6790044 for
further information. (Martin Keane)
1. Corr C (2004) Drug use among new communities
in Ireland: an exploratory study. Dublin:
Merchants Quay Ireland.
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The first systematic and representative survey of
mental health among the Irish prison population
using standardised research diagnostic methods
was implemented in 2003.1 Using the schedule for
schizophrenia and affective disorders (lifetime
version) and the severity of dependence
questionnaire, researchers assessed the mental
health of five distinct samples within the prison
population. The samples were 615 (7%) men
committed to prison, 232 (50%) men in custody
on remand,2 438 (15%) sentenced men, 94 (9%)
women committed to prison and 92 (90%) women
in prison. In total, 1,471 individuals participated in
the study, of whom 1,285 were men and 186 were
women; one woman commenced but did not
complete the study. Response rates for the five
samples ranged between 71% and 90%. The
sample of men serving sentences was
representative of the population of men serving
sentences (excluding life sentences) with respect to
age, length of current sentence and time spent in
prison. 
According to the authors, between 61% and 74%
of prisoners had a substance use disorder at the
time of the survey, with little difference between
the proportions of men and women (Table 1).
Between 12% and 23% of men had a mental
illness (excluding a substance use disorder). The
rate of current mental illness for women was not
reported. Of note, 29% of female committals and
39% of sentenced or remanded women had had a
mental illness in the six months prior to the study.
The authors reported that a number of prisoners
with mental illness also had a substance misuse
disorder. The rate of drug dependence was higher
than the rate of alcohol dependence among male
committal and sentenced prisoners. Higher
proportions of women than men were attending
drug treatment (including methadone substitution)
prior to committal. (Jean Long)
1. Kennedy H, Monks S, Curtin K, Wright B,
Linehan S, Duffy D et al. (2005) Mental illness in
Irish prisoners: psychiatric morbidity in sentenced,
remanded and newly committed prisoners. Dublin:
National Forensic Mental Health Service. 
2. Linehan S, Duffy D, Wright B, Curtin K, Monks S
and Kennedy H (2005) Psychiatric morbidity in a
cross-sectional sample of male remanded
prisoners. Irish Journal of Psychological Medicine,
22 (4): 128–132.
Substance use among the Irish prison
population
Table 1   Rates of current other mental illnesses, with 95% confidence intervals,
attendance at drug treatment prior to committal and current methadone
substitution in the Irish prison population in 2003
Male Male Male Female Female
committal remand sentenced committal sentenced
prisoners1 prisoners2 prisoners1 prisoners1 and remand
prisoners1
(615) (232) (438) (94) (92)
% (95% CI)
Substance use disorder 60.6 (56.7–64.4) 65.6 (61.5–69.5) 73.7* 65.6 (55.5–74.5) –
Alcohol abuse and 
dependence 36.2 (32.2–39.8) 34.7 (30.9–38.8) – – –
Alcohol dependence 23.4 (20.2–26.9) 27.6 (24.0–31.5) 45.1* – –
Drug dependence 32.8 (29.5–37.0) 43.3 (39.3–47.6) 58.8* – –
Mental illness 
(excluding substance 
use disorder) 11.9 (9.6–14.8) 19.0 (14.4–24.5) 22.6* – –
Co-morbid substance 
use and mental illness 7.4 (–) – – – –
Attended drug 
treatment prior to 
committal 16.5 12.2 5.5 35.5 29.3
Currently receiving 
methadone substitution 16.7 14.3 3.9 35.5 34.8
– Not reported
* Weighted percentage
In 2001 the Northern Ireland administration
adopted a ‘joint implementation model’ for its
alcohol and drugs strategies.1 In 2005 it published
the results of a review of the two strategies and
their joint implementation.2 Twelve months later,
on 8 May 2006, it took the next step, launching a
combined strategy – New Strategic Direction for
Alcohol and Drugs 2006–2011 (NSD).3
Professor Howard Parker, who undertook the
review of the two strategies and their
implementation,2 reported that the majority of
stakeholders were in favour of merging the alcohol
and drug strategies as alcohol was ‘routinely
marginalised in terms of investment’ (p. 45). While
some thought tobacco should be included, others
feared this might lead to an over-emphasis on the
health aspects and marginalise other components
such as enforcement or community safety.
Parker also found that stakeholders strongly
supported joint implementation. Local practitioners
recognised the interplay of alcohol and drugs in
their work and, at a policy level, the overlaps
between the youth and criminal justice systems,
and prison and workplace policies, were
recognised. Parker also noted that ‘in such a small
country joint implementation is necessary to
produce economies of scale’ (p. 45).
The ‘overall aim’ of the combined strategy (NSD)3
is ‘to reduce the level of alcohol and drug-related
harm in Northern Ireland’. Four ‘overarching
long-term aims’ focus on demand-reduction
measures in relation to both alcohol and drugs in
the areas of treatment, harm reduction, awareness,
and prevention. There is just one over-arching
long-term aim on the supply side – to ‘reduce the
availability of illicit drugs in Northern Ireland’. An
annual progress report will be published, reporting
against a series of ‘key indicators’, nine each for
alcohol and for illicit drugs. 
The authors of the NSD have designed a planning
framework based on a ‘logic model’. While more
complex than the simple linear approach adopted
in Ireland’s National Drugs Strategy,4 arguably the
NSD framework will prove more flexible and
adaptable. It is constructed around three
inter-related components:
■ Five pillars (prevention and early intervention;
treatment and support; law and criminal
justice; harm reduction; and monitoring,
evaluation and research) provide the
‘conceptual and practice base’, i.e. identify
the inputs to be made by service providers.
■ Two themes (children, young people and
families; and adults and the general public)
provide for an ‘integrated and co-ordinated
approach to be developed incorporating
elements of the five pillars as appropriate’, i.e.
ensure a client focus.
■ Fourteen key priorities (including
development of a four-tier service model and
children’s services; promoting good-practice
education and prevention programmes;
targeting those at risk and vulnerable;
addressing under-age and binge drinking;
reducing illicit drug availability and use;
tackling anti-social behaviour; addressing
community issues; developing effectiveness
indicators for treatment; supporting
harm-reduction approaches; and developing
the workforce) will ‘form the cornerstone of
work over the next five years and reflect the
issues identified as of crucial importance
through the Review and the extensive
pre-consultation exercise’, i.e. ensure the
relevance of the NSD.
To draw these components together in pursuit of
the overarching long-term aims of the NSD, the
various work programmes and activities are
grouped under eight outcomes: 
1. Children, Young People and Families
(Treatment and Support)
2. Children, Young People and Families
(Prevention and Early Intervention)
3. Adults and the General Public (Treatment and
Support)
4. Adults and the General Public (Prevention and
Early Intervention)
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Northern Ireland launches combined
alcohol and drugs strategy
While more
complex than the
simple linear
approach adopted
in Ireland’s
National Drugs
Strategy, 
arguably the NSD
framework will
prove more
flexible and
adaptable.
Alcohol – Key indicators
■ Numbers referred to treatment 
■ Hospital admissions – primary and secondary
diagnosis
■ Alcohol-related deaths
■ Binge drinking target
■ Prevalence (hazardous drinking; problem
drinkers)
■ Per capita consumption or expenditure
■ Alcohol-related crime
■ Drink-driving
■ Public perceptions of alcohol as a social
problem
Drugs – Key indicators
■ Numbers referred to treatment
■ Hospital admissions – primary and secondary
diagnosis
■ Drug-related deaths
■ Blood-borne viruses among injecting drug
users
■ Prevalence (including problem prevalence)
■ Drug-related crime
■ Drug-driving
■ Disruption of supply markets
■ Public perceptions of drugs as a social
problem
Barry and colleagues1 completed a study estimating
the prevalence of alcohol, cigarette and illicit drug
use by women attending the Coombe Women’s
Hospital between 1988 and 2005. The researchers
examined the association between substance use
and immediate outcomes for the newborn baby in
the light of the recommendations of the Second
Report of the Strategic Task Force on Alcohol2 that
deal with alcohol use and pregnancy. These were:
■ Encourage pregnant women and women who
are planning to become pregnant to avoid
alcohol consumption, especially during the
critical first trimester of pregnancy.
■ Require a health-warning label on all alcohol
products and alcohol promotional materials
(p.39)
Anonymous data were extracted from a
computerised database maintained by nursing and
clerical staff at the hospital. In June 1999, some
questions on the database were revised and new
questions were added. This article presents results
from 1 June 1999 to 30 March 2005. 
Table 1 presents alcohol use before and during
pregnancy between 1999 and 2005. Of the 36,108
women who consumed alcohol prior to pregnancy,
4,752 (13.2%) stopped during their pregnancy. 
Of the 3,947 women who consumed six or more
units per week prior to becoming pregnant, only
876 (22%) stopped drinking during their
pregnancy; this is a matter of concern. Level of
alcohol use during pregnancy was not positively or
negatively associated birth weight or the baby’s
ability to breathe spontaneously at birth. 
5. Adults and the General Public (Anti-Social
Behaviour)
6. Monitoring, Evaluation and Research
7. Workforce Development
8. Other
Timeframes for the achievement of these
outcomes, comprising short-term (18-month),
medium-term (3-year) and long-term (5-year)
outcomes, are specified. During the lifetime of the
NSD, these outcomes will be measured and the
overall success or otherwise of achieving the
long-term aims will be measured by the Key
Indicators described above. 
The structure of institutional mechanisms to
oversee the implementation and co-ordination of
the NSD is based on the same principles as those
applied in Ireland’s National Drugs Strategy. One
innovation is the appointment of four ‘advisory
groups’ – on children, young persons and families;
on treatment and support; on law and criminal
justice; and on binge drinking. These advisory
groups will advise the New Strategic Direction
Steering Group (the equivalent of our National
Drugs Strategy Team) in respect of the particular
issues, comment on particular work towards the
outcomes of the NSD, and make recommendations
as to future work and directions. Stakeholders and
local communities, including service users, will be
represented on these advisory groups. (Brigid Pike)
1. Model for the Joint Implementation of the Drug
and Alcohol Strategies (May 2001)
www.dhsspsni.gov.uk/jointdrug.pdf
2. H Parker (2005) Better managing Northern
Ireland’s alcohol and drug problems – A review of
the NI alcohol and drug strategies and the
efficiency and effectiveness of their implementation
(March 2005) www.dhsspsni.gov.uk/drugs-
alcohol-Report-NI-review.pdf 
3. New Strategic Direction for Alcohol and Drugs
2006–2011 (May 2006) www.dhsspsni.gov.uk/
nsdad-finalversion-may06.pdf 
4. Building on experience: National Drugs Strategy
2001–2008. Dublin: Department of Tourism,
Sport and Recreation. www.pobail.ie/en/
NationalDrugsStrategy/NationalDrugsStrategy
Overview/file,2229,en.pdf
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Self-reported substance use by women
attending the Coombe Women’s Hospital
Table 1   Alcohol use before and during pregnancy, 1999 to 2005 (43,318 women)
Before pregnancy During pregnancy
Amount of alcohol consumed Number (%)
No alcohol 7,210 (16.6) 11,962 (27.6)
1 to 5 units per week 28,197 (65.1) 24,300 (56.1)
6 or more units per week 3,947 (9.1) 3,071 (7.1)
Not recorded 3,964 (9.2) 3,985 (9.2)
Table 2 presents the increase between 2000 and
2005 in the proportion of women who stopped
smoking during pregnancy. As the number of
cigarettes smoked increased the likelihood of
delivering a baby weighing less than 2,500 grams
increased, indicating a direct and visible negative
outcome associated with smoking (Table 3). 
Overall, the reduction in consumption of alcohol, a
potentially harmful substance, is very low and
compares unfavourably with the increasing
numbers of women who stopped smoking during
their pregnancy (Table 2). It is apparent that the
dangers of smoking were clearly understood by
women attending the hospital and that the
dangers of alcohol were not. This indicates a need
to highlight the dangers of alcohol use for the
foetus and for the child’s long-term development.
The major negative outcome of alcohol
consumption during pregnancy is the development
of foetal alcohol spectrum disorder, which
comprises partial and complete foetal alcohol
syndrome as well as alcohol-related neuro-
development disorder. The latter disorder includes
neuro-behavioural effects, which can develop from
lower levels of alcohol consumption and manifest
themselves in children and adolescents as attention
and behavioural difficulties. 
In total, 447 (1.0%) women reported using drugs
associated with dependency during their
pregnancy (Table 4). However, it is difficult to
comment on these figures as it is not clear how
many were using methadone or diazepam as a
treatment rather than in an unregulated manner
(street use). A higher proportion of women who
reported drug use (16.6%) were likely to have a
baby weighing less than 2,500 grams than the
proportion of women who did not report drug 
use (5.1%). 
According to the authors, the pertinent
recommendations of the Strategic Task Force on
Alcohol need to be implemented and substance
use during pregnancy needs to be monitored. 
In addition, the authors recommend that a
surveillance system be established to detect infants
with foetal alcohol spectrum disorder. (Jean Long)
1. Barry S, Kearney A, Lawlor E, McNamee E and
Barry J (2006) The Coombe Women’s Hospital
study of alcohol, smoking and illicit drug use,
1988–2005. Unpublished.
2. Strategic Task Force on Alcohol (2004) Second
report. Dublin: Department of Health and
Children.
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Self-reported substance use by women attending the Coombe
Women’s Hospital (continued)
It is apparent 
that the dangers
of smoking 
were clearly
understood by
women attending
the hospital and
that the dangers
of alcohol were
not.
Table 4   Drug use during pregnancy, 1999
to 2005 (43,318 women)
During pregnancy
Drugs used Number (%)
Yes 447 
Type of drug used*
Methadone† 323
Cannabis 87
Heroin 64
Diazepam† 51
Ecstasy 14
Cocaine 13
*The total number of drugs is greater than the
total number of women as some women used
more than one drug.
† These numbers do not discriminate between
prescribed and street use. 
Table 2   Percentage of pregnant women who stopped smoking during pregnancy, 
2000 to 2005 
2000 2001 2002 2003 2004 2005
Stopped smoking during pregnancy 41.8 43.0 44.5 50.8 52.4 53.5
Table 3   Percentage of women who delivered a baby weighing less than 2,500 grams, 
by smoking status, 1999 to 2005
Stopped 5 or less 6 to 10 11 to 20 21 or more
smoking during cigarettes cigarettes cigarettes cigarettes
pregnancy per day per day per day per day
Baby weighed less than 
2,500 grams 3.4 6.0 8.5 9.6 13.1
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The first strategic plan of the Western Region
Drugs Task Force (WRDTF), entitled Shared
Solutions, was published this year (2006).1
The WRDTF was established in 2003. It covers
counties Galway, Mayo and Roscommon (GMR).
Shared Solutions incorporates the discussions of the
WRDTF, local views expressed during two ‘Open
Space’ consultation events held in November
2004, as well as information presented in a range
of regional and national policy documents,
research reports and other literature. The strategic
plan takes the ‘four pillars’ of the National Drugs
Strategy as its main themes: research; prevention
and education; treatment; and supply reduction.
Despite the fact that Ireland’s national alcohol and
drugs strategies are managed separately, the
WRDTF decided early on to include alcohol in its
first strategic plan. The plan explains the reason for
this decision: ‘This decision reflects the reality that
alcohol is the main problem drug nationally and
regionally, and that the nature of substance misuse
in our society does not necessarily follow lines
neatly drawn by political, legal, social or
institutional definitions.’ 
The strategic plan sets out a broad framework for
integrated action and highlights the many
inter-related issues to be addressed in the short,
medium and long term. One of the broad aims of
the strategic plan is to strengthen the protective
factors that will assist communities, families and
individuals to deal with substance use in the future.
Shared solutions
The shared solutions approach acknowledges that
no one agency can tackle all drug-related problems
on its own. However, joint planning and forward
thinking may facilitate the development of shared
solutions and integrated service planning that will
address the drug and alcohol problem early and
reduce the harmful impact of drug and alcohol
misuse. This approach requires co-ordination,
shared values and inter-agency co-operation.
The WRDTF intends to take a co-ordinating role in
the development of projects specifically designed
to prevent or tackle drug and alcohol misuse. ‘The
Task Force wants to work with agencies and
communities in urban and rural areas to identify
their own needs, develop their own plans and
prioritise their own developments.’ It intends to
Shared Solutions: First strategic plan of
the Western Region Drugs Task Force
Task Force staffing and setup
■ Task Force co-ordinator
■ Project worker
■ Administrator
■ Training budget
■ Website development
■ Accommodation
Measures to address gaps in services
■ Four community liaison posts, in Galway city
and county, Mayo and Roscommon, in order
to link the social inclusion measures working
group of each county development board.
■ Three education support workers to support
the implementation and ongoing delivery of
the SPHE (Social, Personal and Health
Education) programme and other
community-based education programmes
around substance misuse issues.
■ Three nurses to provide community-based
drug and alcohol detoxification, one for
each county (GMR). 
■ Substance misuse worker for the homeless,
who will develop a pilot project to engage
with homeless people in the hostels and
support projects. 
■ Pharmacy liaison worker to work with
pharmacists, GPs and relevant agencies on
the issue of misuse of benzodiazepines and
other medicines. The pharmacy liaison
worker will also offer training and support to
pharmacists and work with them in relation
to the development of a needle-exchange
programme.
■ Three community substance misuse brief
intervention counsellors based in the
third-level colleges (National University of
Ireland, Galway and Galway Mayo Institute
of Technology).
■ Substance misuse consultant post
■ Local inpatient detoxification beds to
provide specialist inpatient alcohol and drug
detoxification.
■ Regional inpatient drug and alcohol
treatment unit to replace the addiction
treatment unit closed down in 2003.
■ Funding to purchase rehabilitation places for
drug and alcohol clients in existing
programmes.
■ Funding to develop a residential support
service for homeless people.
Grants for
■ community-based projects
■ education, information and support for
families affected by addiction 
■ primary prevention initiatives for young
people
Research 
■ Substance misuse in the Traveller
community
■ Misuse of benzodiazepines and other
medicines
■ Service delivery for marginalised groups
■ Evaluation of Task Force Implementation
Plan
Problem drug use can lead to premature death.
Deaths can occur as a result of overdose (both
intentional and unintentional), actions taken under
the influence of drugs, medical consequences and
incidental causes. Drug-related deaths and
mortality among drug users are indicators of the
consequences of problem drug use in Ireland. 
The data presented in this article provides the
number of direct-drug-related deaths between
1980 and 2003, based on unpublished data from
the Central Statistics Office (CSO). Direct
drug-related deaths are those occurring as a result
of overdose. At the European level, the European
Monitoring Centre for Drugs and Drug Addiction
(EMCDDA) has developed a standardised method
for extracting data on drug-related deaths from the
mortality registers in all member states.1 Staff at the
CSO2 extracted and collated the data in April 2006,
using the EMCDDA’s ‘Selection B’ definition of
drug-related death. 
Figure 1 presents the numbers of direct-drug-
related deaths in Ireland between 1980 and 2003,
extracted from the General Mortality Register.
There were few deaths in the eighties. Between
1990 and 1994, there was a small but steady
increase in the number of drug-related deaths, and
between 1995 and 1999 a substantial increase.
This was followed by a considerable decline in the
number of deaths between 2000 and 2002. In
2003, the number of drug-related deaths increased
marginally when compared to 2001 and 2002. 
Between 2001 and 2003, 60% of direct
drug-related deaths were opiate-related.
Figure 2 presents the numbers of direct
drug-related deaths in Dublin and in the rest of
Ireland between 1980 and 2003. 
According to data from the General Mortality
Register, almost all direct drug-related deaths
between 1980 and 1994 occurred in Dublin.
Between 1995 and 1999, there was a substantial
increase in drug-related deaths in Dublin, from 33
to 96; and there was a steady increase in
drug-related deaths outside the Dublin area, from
3 to 26. 
Between 2000 and 2003, there was a sharp decline
in direct drug-related deaths in Dublin, from 83 in
2000 to 46 in 2003. This possibly reflects the
decrease in new opiate users, the increase in
methadone treatment places, the reduction in
average waiting times for methadone treatment
and the provision of methadone treatment in the
Dublin prisons. 
During this period there was a continued increase
in drug-related deaths outside Dublin, from 30 in
2000 to 50 in 2003. In 2003, the number of
drug-related deaths outside Dublin exceeded the
number of drug-related deaths in Dublin for the
Update on direct drug-related deaths in
Ireland
drugnet
IRELAND
20
Between 1990 
and 1994, there
was a small but
steady increase 
in the number of
drug-related
deaths, and
between 1995 
and 1999 a
substantial
increase.
integrate with existing structures, such as county
development boards, social inclusion working
groups, community forums and so on, in order to
support these development plans. 
The consultation process identified service gaps
and other problems. The strategic plan includes an
outline of proposed developments and their
indicative costs. The proposed developments are
grouped under four main themes: Task Force
staffing and setup, measures to address gaps in
services, grants and research (see table). 
The consultation process and research review
highlighted a number of key issues which require
further analysis and consideration:
Protective factors – planning in order to reduce
exposure to drug and alcohol misuse
Early intervention and treatment – providing
early access to help or treatment
Rehabilitation and relapse prevention –
maintaining a drug-free lifestyle
Relevance and need – projects must be drug or
alcohol related, and directly relevant to the
objectives of the regional and national drug
strategies
Monitoring and evaluation – all projects will be
subject to monitoring and evaluation criteria
Value for money – projects or initiatives must
demonstrate value for money
The full complement of task force staff has now
been appointed and the full-time co-ordinator is
due to take up the post in the near future. This,
along with the provision of appropriate funds, will
enable the development and implementation of an
operational plan. It is acknowledged that the
practical work of the WRDTF is only beginning.
Considerable effort and commitment is required in
order to address the problems relating to
substance misuse, and to develop and strengthen
the inter-agency partnerships needed to make real
progress. (Sarah Fanagan)
1. Western Region Drugs Task Force (2006) Shared
Solutions: First strategic plan of the Western Region
Drugs Task Force. Castlebar: Western Region
Drugs Task Force.
Shared solutions (continued)
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The approach to
opiate treatment
in Dublin has
been successful.
first time. The data for outside Dublin follow trends
in problem opiate use in that geographical area. 
The approach to opiate treatment in Dublin has
been successful. It is likely that the introduction of
opiate treatment in prisons and the reduction in
average waiting times, in conjunction with the
increase in methadone treatment places, have been
key strategies in achieving this reduction. A similar
approach to the management of problem opiate
use is required outside Dublin. (Jean Long, Ena Lynn
and Lorraine Coleman)
1. EMCDDA (2002) The DRD-Standard, version 3.0:
EMCDDA standard protocol for the EU Member
States to collect data and report figures for the key
indicator drug-related deaths by the standard
Reitox tables. EMCDDA project CT.02.P1.05.
Lisbon: European Monitoring Centre for Drugs
and Drug Addiction. 
2. The authors would like to thank Joseph Keating
at the Central Statistics Office for extracting and
collating the data on direct drug-related deaths
from the General Mortality Register. 
Update on drug-related deaths (continued)
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Figure 1   Number of direct drug-related deaths in Ireland reported by the CSO, 1980 to
2003 (unpublished data from the vital statistics)
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Figure 2   Number of direct drug-related deaths in Ireland, by place of death, reported by
the CSO, 1980 to 2003 (unpublished data from the vital statistics
The first quarter of 2006 saw intense policy activity
at international level. As UN drug bodies reported
on the world drug control situation and considered
policy options, international NGOs also offered
their views.
A key event was the 49th Session of the
Commission on Narcotic Drugs (CND), the central
UN policy-making body dealing with drug-related
matters, held in Vienna between 13 and 17
March.1 The Session developed proposals to
strengthen the international drug control system
and to reduce the demand for drugs. 
In respect of the control of drugs and precursors,
the CND Session passed resolutions calling for,
among other things:
■ the use of alternative development
programmes to reduce the cultivation of
cannabis plants, especially in Africa
■ stronger systems for the control of precursor
chemicals used in the manufacture of
synthetic drugs, including ecstasy,
methamphetamine and amphetamine
■ the listing of ketamine as a controlled
substance by member states. 
In Ireland ketamine is authorised as a prescription
drug by the Irish Medicines Board. The Board
states: ‘If used on a daily basis for a few weeks,
dependence and tolerance may develop,
particularly in individuals with a history of drug
abuse and dependence. Therefore the use of
Ketamine should be closely supervised and it
should be prescribed and administered with
caution.’2
In response to the prevalence of HIV/AIDS and
other blood-borne diseases among drug users, the
CND Session passed a resolution calling for
member states to:
■ adopt actions based on studies and research
that demonstrate the efficacy and efficiency of
drug-related treatment and prevention;
■ adopt drug-related health policies that
facilitate prevention of drug abuse and access
by drug users to different types of prevention,
treatment and care for drug dependency,
drug-related HIV/AIDS, hepatitis and other
blood-borne diseases;
■ enhance efforts to promote access to health
and social care for drug users and their
families without discrimination of any kind
and, where appropriate, to co-operate with
relevant non-governmental organisations;
■ provide access, as appropriate and in the
framework of the pertinent national policies,
to medications, vaccines and other measures
that are consistent with international drug
control treaties and have been shown to be
effective in reducing the risk of HIV/AIDS,
hepatitis and other blood-borne diseases
among injecting and other drug users, under
the supervision of the competent authorities
or institutions.
While noting that the CND resolution does not
mention access to sterile injection equipment, the
International Harm Reduction Association (IHRA)
notes that it does refer to recent decisions of the
Programme Coordinating Board (PCB) of the
UNAIDS: ‘This could be interpreted as an
endorsement of the June 2005 global HIV
prevention paper adopted at the PCB, which
supported access to sterile injection equipment.’3
The CND Session held a thematic debate on
alternative development (AD) as a drug control
strategy. Most countries agreed that AD should
integrate demand reduction, health and education
and sustainable development efforts as well as crop
eradication and law enforcement activities, and
that it should be evaluated in terms not just of
illicit crop reduction but also of social, economic
and human development indicators.1 In parallel
with the CND Session, the Senlis Council, an
international security and development think-tank,
hosted the 7th International Symposium on Global
Drug Policy: ‘Bridging Security and Development’.
The Senlis Council is critical of AD programmes,
arguing that crop eradication has destroyed whole
communities and been ineffective in lowering
production. The Council is calling for licensing
schemes that would allow farmers to cultivate
crops such as opium for medical use.4
With regard to the world drug situation, the CND’s
deliberations were informed by the World Drug
Report 2005, published in the weeks leading up the
CND Session by the International Narcotics Control
Board (INCB), the independent and quasi-judicial
monitoring body for the implementation of the UN
international drug control conventions.5 The role of
the INCB itself has come under close scrutiny. In
February 2006 the Beckley Foundation Drug Policy
Programme (BFDPP), a UK-based project dedicated
to providing a rigorous, independent review of
global drug policy, published a report exploring
whether the INCB is ‘watchdog’ or ‘guardian’ of
the UN drug control conventions. It argues that, by
becoming guardian of the ‘purity of the
conventions’ rather than watchdog, describing the
situation and drawing attention to challenges and
dilemmas, ‘the Board undermines its own
authority, and runs the risk of being seen as
irrelevant to the shifting challenges faced by
national governments and municipal authorities in
responding to the widespread use of illegal drugs.’6
On 1 March the Senlis Council announced its
interest in the INCB, with the establishment of an
expert panel to review its effectiveness. In
anticipation of the upcoming review of global drug
policy at the UN General Assembly Special Session
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UN drugs policy under scrutiny
in 2008, the Panel will present a series of
recommendations for reform of the INCB at the
2007 CND Session in Vienna.4 (Brigid Pike)
1. Commission on Narcotic Drugs (2006) Report on
the forty-ninth session (8 December 2005 and
13–17 March 2006) Economic and Social
Council Official Records 2006, Supplement No.
8. (E/2006/28; E/CN.7/2006/10.)
www.unodc.org/unodc/en/cnd.html 
2. Irish Medicines Board ‘Human Medicines: List of
Human Authorised and Transfer Pending
Products’. CRN 2021355, printed 24/3/2005.
www.imb.ie 
3. International Harm Reduction Association (2006)
‘Commission on Narcotic Drugs – more support
for harm reduction’. News Preview, 17 April
2006. Viewed 1 June 2006 at www.ihra.net 
4. For further information on the Senlis Council,
visit www.drug-policy.org 
5. International Narcotics Control Board (2005)
Report of the International Narcotics Control Board
for 2005 (E/INCB/2005/1) www.incb.org 
6. Bewley-Taylor D and Trace M (2006) The
International Narcotics Control Board: Watchdog
or Guardian of the UN Drug Control Conventions?
Report 7. Oxford: Beckley Foundation Drug
Policy Programme, February 2006. Viewed 1
June 2006 at www.internationaldrugpolicy.net 
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UN drugs policy (continued)
Drug testing at work
Cited from Brendan Hughes Drugnet Europe No. 54,
April–June 2006
Following discussion of the legal aspects of
workplace drug testing at the legal correspondents
meeting in September 2005, a new topic overview
has been published on the European legal database
on drugs (ELDD). This outlines international,
European and national legislations on the subject.
Workplace drug testing is a complex topic that is
rarely regulated directly; much of the legal
framework comes from interpretations of a
combination of various laws, including those on
labour codes, privacy, data protection, and health
and safety at work. Nevertheless, new laws have
recently been passed by Ireland, Finland and
Norway to regulate the issue. Ireland reported that
the legislation was welcomed by all parties, as it
brought legal clarity to procedures that were
already implemented by employers.
The topic overview is available at
http://eldd.emcdda.europa.eu/?nnodeid=5036
E-POD: a case study of hallucinogenic
mushrooms
Cited from Jennifer Hillebrand, Deborah Olszewski
and Roumen Sedefov Drugnet Europe No. 54,
April–June 2006
The EMCDDA is in the process of developing a
pilot project, E-POD (European Perspectives on
Drugs), to explore to explore the capacity in EU
Member States to detect, track and understand
emerging drug trends using methods that depend
on the triangulation of a wide range of different
sources to assess the veracity of accumulated
information.
The E-POD project follows the European Trend
project and utilises data made available by the
early warning system on new drugs and the Reitox
network. It will contribute to the implementation
of the EU drugs action plan (2005–2008) objective:
to ‘develop clear information on emerging trends
and patterns of drug use and drug markets’,
provide better understanding of the drugs
phenomenon and thereby help with the
development of responses.
New EMCDDA website address 
Since 9 May 2006, the EMCDDA’s website address
has changed to www.emcdda.europa.eu. The old
website address (www.emcdda.eu.int) will continue
to work until May 2007, with traffic being
automatically redirected to the new domain name
when necessary during this interim period.
From Drugnet Europe
Drugnet Europe is the quarterly newsletter of the
European Monitoring Centre for Drugs and Drug
Addiction (EMCDDA). An electronic version of
Drugnet Europe is available on the EMCDDA
website at www.emcdda.europa.eu
If you would like to receive a hard copy of the
current or future issues of Drugnet Europe, please
contact Charlene Lydon, Drug Misuse Research
Division, Health Research Board, Knockmaun
House, 42–47 Lower Mount Street, Dublin 2. 
Tel: 01 676 1176 ext 127; Email: dmrd@hrb.ie
Copping On National Crime Awareness Initiative
Welcome to the fifteenth EDDRA (Exchange on
Drug Demand Reduction Action) column. The aim
of this column is to inform people about the
EDDRA online database, which provides
information on good practice interventions to
policy makers and those working in the drugs area
across Europe, and to promote the role of
evaluation in reducing demand for drugs. The
database is co-ordinated by the European
Monitoring Centre for Drugs and Drug Addiction
(EMCDDA). 
This article will look at the findings from a recent
evaluation of the Copping On National Crime
Awareness Initiative.1 This initiative has been
included on the EDDRA database as an example of
good practice in working with young people at
risk. An important requirement of good practice is
a willingness to evaluate and improve an
intervention by developing a focused and strategic
plan. The evaluation of Copping On was
commissioned to assist in the development of a
strategic plan. 
The Copping On National Crime Awareness
Initiative is now celebrating its tenth anniversary.
The initiative was established to provide crime
prevention and awareness training to groups
working with young people at risk, such as
members of the Probation and Welfare Service, the
Garda, and youth workers. The City of Dublin
Vocational Educational Committee (CDVEC)
administers the programme and the Department of
Education, the Department of Justice and FÁS
provide funding. The two-day training course
delivered to participating groups covers
communications, relationships, drugs and alcohol,
decision making and the role of the justice system
in society – all relevant issues in the lives of the
young people that these groups work with. Junior
and senior resource packs are provided to enable
participants to structure their work with at-risk
young people around the central themes of the
initiative. 
The evaluators sought the views of a small number
of young people who received training from
trained facilitators based on the Copping On
material. Of the sessions delivered to the young
people, those that had most impact were the
prison visit, drug and alcohol awareness and
discussion on stereotyping. Overall, it appeared
that the young participants gained a better
understanding of the consequences of choices they
made. 
The evaluation also surveyed 420 programme
participants, of whom 91 (22%) responded. Some
key findings from this survey were: 
■ 57% of respondents felt that the training was
highly or very useful, and 40% gave it a
rating between very low and medium
usefulness.
■ 46% used the training for crime prevention
purposes only, and 53% for other purposes.
■ Respondents reported using Copping On
material with approximately 1,250 young
people.
■ 57% agreed that the current programme
content fitted their needs.
■ 61% would like Copping On to develop a
DVD for crime awareness work with young
people; 57% would like training on
re-offending; 49% would like training and
resources to assist in work with young people
with low literacy levels; and 48% would
favour greater focus on work with the families
of young people at risk.
■ 78% had used the resource packs and
reported them to be user friendly.
■ 78% had not attended follow-up training.
■ 41% believed that the Copping On initiative
had changed their approach to crime
awareness work with young people. 
The evaluation contains a number of key
recommendations designed to improve the
strategic focus and location of Copping On, build
on and develop its evaluation culture and develop
its capacity to respond to the changing needs of
the main target groups. Two specific
recommendations are: 
■ Training should expand to focus on young
people with low literacy levels, families of
young people at risk and those at risk of
re-offending.
■ Copping On should expand and update its
data-collection system to include information
on levels of participant delivery of
programmes to young people, the impact of
the programme on young people, follow-up
training and project visits and how the
programme can continue to meet the needs
of the target groups. 
A copy of the evaluation is available in the
publications section of the Copping On website at
www.coppingon.ie (Martin Keane)
1. Duffy A (2005) Evaluation Report: Copping On
2000–2004. Dublin: Copping On National
Crime Awareness Initiative.
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The EDDRA column
If you have an
intervention that has
been evaluated and you
wish to highlight your
work and share the
information from your
evaluation with a
national and
international audience,
please contact Martin
Keane, EDDRA Manager,
at 01 6761176 ext 169
or Email:
mkeane@hrb.ie
Staff from SIRUS, the Norwegian EMCDDA focal
point, on a visit to the DMRD. L to r: Mr Anders
Bryhni, Dr Hamish Sinclair (DMRD), Mr Odd
Hordvin and Ms Hege Lauritzen (EDDRA
Manager, SIRUS)
In Issue 16 of Drugnet Ireland we looked briefly at
the concept of evidence-based medicine (EBM).
This article will examine some of the issues around
finding reliable evidence on substance use
treatment and prevention and will review some of
the recent literature on this subject.
EBM and addiction
Reimer1 points out that the efficacy of the
evidence-based approach to clinical practice is by
no means universally accepted. Criticism focuses
on the narrow range of reliable research methods
accepted by the approach and difficulties in
interpreting and applying the results of
meta-analysis and systematic reviews. The fields of
substance use treatment and prevention are not
immune to the debates surrounding the
appropriateness of EBM. However, a number of
factors not directly related to the application of
evidence-based treatments in the clinical setting
have contributed to EBM’s increasing relevance in
the addictions field. Reimer identifies these factors
as:
■ an increasing emphasis on accountability and
evidence of effectiveness from governments
and funding agencies, particularly since the
early 1990s
■ the importance to healthcare policy of
standardised treatment procedures,
cost-effectiveness and outcomes 
■ the recognition, by those delivering services
in the community, of the importance of
delivering empirically supported therapies as
funding sources increasingly emphasise
best-practice guidelines.
Despite this supportive environment, the body of
evidence available to practitioners wishing to
pursue an evidence-based approach to treatment
and prevention is small. Lacroix2 explains that the
dominance of the disease model of addiction
meant that the introduction of non-medical
therapies occurred relatively recently. Addiction
medicine developed rapidly as a separate discipline
in the US in the immediate post-war period. But it
was not until the 1980s that a more complex
understanding of the nature of addiction emerged
and psychologists and counsellors began to apply
different models of treatment. Therefore, the study
of addiction has not yet produced a body of
evidence-based knowledge comparable with that
of other branches of medicine and health science. 
Sources of evidence
The number of systematic reviews and practice
guidelines developed for non-medical treatments is
very small. The Cochrane Database of Systematic
Reviews is divided into a number of thematic
review groups. The Drug and Alcohol Group and
the Tobacco Addiction Group are the review
groups of most interest to those studying addiction
treatments. Of a total of 31 completed systematic
reviews published in the current issue (2, 2006) by
the Drug and Alcohol Group, only seven dealt
primarily with psychosocial or other
non-pharmaco-therapy interventions. There were
no such reviews in Issue 4, 2001, so interest is
increasing. However, in many of the recent studies
the outcome was inconclusive because of
inadequate or incomplete research. 
The Medline database is the main source of
bibliographic information on medical literature and
it is possible to select literature for evidence-based
decision making from it. By limiting publication
types to meta-analysis, practice guidelines or
randomised controlled trials, it is possible to
estimate the volume of literature dealing with
evidence-based approaches to treatment for
addiction and substance use disorders. Only about
2% of the total number of articles in this category
deals primarily with non-medical or psychosocial
interventions. It would be necessary to consult a
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The National Documentation Centre on
Drug Use
Students from An Cosán educational project in Tallaght who are studying for a Diploma in Community
Drugs Work in UCD with Dr Aileen O’Gorman, UCD, and Ms Anne O’Keefe, An Cosán, on a visit to the
National Documentation Centre.
number of sources to carry out a useful literature
review in this area. Other databases which might
produce relevant material include PsycINFO, the
database of the American Psychological
Association; ETOH, the Alcohol and Alcohol Problems
Science Database (not updated since 2004 but still
a valuable source of literature in this area); and
DrugData, maintained by the library of DrugScope
in the UK. 
Several medical organisations in the US publish
practice guidelines on substance use treatment,
many of which are available online through the
National Guidelines Clearing House database
(www.guidelines.gov). Finney3 explains the
difficulty in developing comprehensive, useful
practice guidelines for behavioural and
psychosocial approaches to treatment. Such
guidelines do exist, but they are not as easy to
locate as medical guidelines. Finding appropriate
ones may involve a detailed literature search and
an examination of the publications produced by
relevant research centres and well-known
researchers in the field. 
Recent publications
A number of recent publications reviewing
literature in the addiction field are useful for
identifying high-quality research. Stockwell et al.4
provide a summary of recent research on aspects of
prevention work and assess the effectiveness of
various intervention strategies described in the
available research. Lingford-Hughes et al.5 wrote a
very useful review of recent research on
pharmacological management of problem drug
use. They argue that, while quality research is
scarce, a wealth of clinical experience can be
drawn on to increase the effectiveness of
treatment. In an American study, McGovern et al.6
examine the process by which treatment
professionals use an evidence-based approach to
select appropriate interventions.
Research transfer
Summarising the literature on the research-to-
practice exchange, Reimer1 identifies three
prerequisites for effective research transfer:
■ relationships need to be developed between
researchers, practitioners and policy makers
■ research evidence and practice guidelines
must be combined with individual instruction,
incentives and active learning strategies
■ research organisations need to devote an
equal amount of funding to research studies
and to research transfer
Research on addiction and substance use cannot,
of course, match that in the medical field in terms
of funding or infrastructural support. Researchers
and information professionals have an important
role in drawing attention to the evidence that does
exist and ensuring that it is used to establish a
sound evidence base for programmes and policy in
the field. (Brian Galvin)
1. Reimer B (2003) Strengthening evidence-based
addictions programs: a policy discussion paper.
Ottawa: Canadian Centre on Substance Abuse.
www.ccsa.ca/pdf/ccsa-010214-2003.pdf
2. Lacroix SI (2002) Evidence-based and
best-practice addiction treatment resources: a
primer for librarians. Behavioral & Social Sciences
Librarian, 21(1): 61–71.
3. Finney JW (2000) Limitations in using existing
alcohol treatment trials to develop practice
guidelines. Addiction, 95(10): 1491–1500.
4. Stockwell T, Gruenewald P J, Toumbourou J W
and Loxley W (eds) (2005) Preventing harmful
substance use: the evidence base for policy and
practice. Chichester: John Wiley.
5. Lingford-Hughes AR, Welch S and Nutt DJ
(2004) Evidence-based guidelines for the
pharmacological management of substance
misuse, addiction and comorbidity:
recommendations from the British Association
for Psychopharmacology. Journal of
Psychopharmacology, 18(3): 293–335.
6. McGovern MP, Fox TS, Xie H and Drake RE
(2006) A survey of clinical practices and
readiness to adopt evidence-based practices:
dissemination research in an addiction treatment
system. Journal of Substance Abuse Treatment,
26(4): 305–312.
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National Documentation Centre (continued)
The National Documentation
Centre will be closed to visitors
from Monday 31 July 2006 and
will reopen on Tuesday 8 August.
During this time, NDC staff will
continue to take telephone and
email queries.
On 1 February 2006 the Courts Service announced that the
Drugs Treatment Court is to be put on a permanent
footing and extended on a staged basis to all court areas in
the Dublin Metropolitan District. www.courts.ie 
On 2 February 2006 Drugs and Doping in Sport: Guidelines
for General Practitioners was published by the Irish Sports
Council and the Irish College of General Practitioners.
www.icgp.ie / www.irishsportscouncil.ie 
On 6 February 2006 the Homeless Agency launched
Preventing Homelessness: A Comprehensive Preventative
Strategy to Prevent Homelessness in Dublin, 2005-2010. The
Strategy acknowledges that drug, alcohol, mental health or
other personal and health problems may lead individuals into
homelessness. www.homelessagency.ie 
On 13 February 2006 the Customs Service launched its
mobile x-ray scanner. Speaking at the launch, Minister Noel
Ahern TD said the scanner would assist in the disruption of
the flow of drugs into the State. www.pobail.ie 
On 13 February 2006 the SDLP published North South
Makes Sense. Under the heading of health and social
services, the document proposes ‘shared provision of
specialised units and services for young people with
drug/alcohol addiction’. In relation to justice and policing, 
it calls for a North/South Criminal Justice Treaty and an
all-Ireland Criminal Assets Bureau, Law Commission and
Intelligence Agency. www.sdlp.ie 
On 17 February 2006 the Financial Action Task Force
(FATF), an inter-governmental body whose purpose is the
development and promotion of national and international
policies to combat money laundering and terrorist financing,
published its assessment of the implementation of its
anti-money-laundering and counter-terrorist-financing
standards in Ireland. It reported that Ireland has a sound
legal framework in place to combat money laundering,
although the number of convictions for money laundering is
‘somewhat low’. www.fatf-gafi.org 
In February 2006 the Dublin Simon Tenancy Sustainment
Service was announced. Intended to break the cycle of
homelessness, the service will prioritise people and families
moving out of homelessness into tenancies, as well as
working with people who are in established tenancies but
who are at high risk of the tenancies breaking down and
thus returning to homelessness. www.dubsimon.ie
On 7–8 March 2006 the National Roads Authority held a
conference on road safety. Three papers were presented
relating to driving under the influence of alcohol or drugs,
including one on ‘Eye Testing for Drugs and Driving’.
www.nra.ie
On 14 March 2006 the report School Matters – The Report
of the Task Force on Student Behaviour in Second Level
Schools was published. Two societal factors identified as
directly affecting schools and the behaviour of students, and
leading in some situations to dysfunctional behaviours in
schools, were ‘youth culture’, which includes clothes,
hairstyles, sexuality, music, technologies and language ‘and,
for some, experimentation with alcohol and drugs’, and 
‘lifestyle’, and in particular young people’s patterns of
drinking. www.education.ie 
On 29 March 2006 the Rainbow Project launched a
research report Out on your Own, examining the mental
health of young same-sex-attracted men in Northern Ireland.
The researchers found that 71.6 per cent of respondents had
tried drugs or solvents at least once. This finding mirrors
international research showing that lesbian, gay and bisexual
(LGB) people are more likely to use recreational drugs than
heterosexual people. www.rainbow-project.org 
In March 2006 the Report of the High Level Group on
Traveller Issues was published by the Department of Justice,
Equality and Law Reform. The report summarises the current
situation and makes recommendations with regard to the
provision of services to Travellers in the areas of
accommodation, health, education and employment. The
Group noted that in 2005 three local drugs task forces (Bray,
Dublin North-East, and South Inner City) were funding
projects specifically targeted towards Travellers. It also noted
that the National Advisory Committee on Drugs has
commissioned an exploratory study of drug use and drug
issues among the Traveller community. www.justice.ie 
In March 2006 the Department of Justice, Equality and
Law Reform undertook a nationwide survey of public
attitudes towards crime and law enforcement issues in
Ireland. The survey revealed high levels of concern regarding
most of the crimes listed, with ‘drug abuse’ being almost
universally seen as the most serious problem. www.justice.ie
On 5 April 2006 the Irish Sports Council launched its 2005
Anti-Doping Annual Report. It reports that in 2005, 962 tests
were carried out. There were two positive findings, for
cannabinoids, one in squash and one in rugby. Sanctions
were imposed. www.irishsportscouncil.ie 
On 18 April 2006 the Task Force on Active Citizenship was
announced by the Taoiseach, Bertie Ahern TD. The Task
Force is due to report in nine months’ time with
recommendations for facilitating and encouraging a greater
degree of engagement by citizens in all aspects of life and
the growth and development of voluntary organisations as
part of a strong civic culture. www.taoiseach.gov.ie 
On 26 April 2006 the Drugs Awareness Programme, with
sponsorship from the Vodafone Ireland Foundation, launched
a new mobile phone text-alert service to provide people with
urgent advice on the dangers of illicit drugs. www.dap.ie 
In April 2006 the Irish Society for the Prevention of
Cruelty to Children (ISPCC) released its Childline Annual
Call Statistics 2005. These figures show that 1,104 (0.94%)
calls were on the subject of substance use; 361 (0.31%) on
alcohol use; and 240 (0.20%) on smoking. In the wake of
the launch of the statistics, the ISPCC called for the
establishment of a new Life Skills Education Programme in
primary schools and the introduction of a nationwide parent
support programme. It claimed that there is growing
evidence that drink and drugs, mobile phone usage, Internet
usage, sexual pressures and mental health are major factors
for children as young as eleven and twelve. www.ispcc.ie 
(Compiled by Brigid Pike)
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In brief
Books
Drug treatment: What works?
Bean P and Nemitz T (eds) 
Routledge 2004, 272 pp.
ISBN 0 415 26817 6
Finding ways of dealing with the burgeoning drug
problem is a major platform of UK government
policy and a great deal has been made of the
impact of treatment on drug users. Drug treatment:
What works? deals with the nature of treatment and
surveys some of the latest developments and
problems associated with providing treatment to
substance misusers, as well as concentrating on
criminal justice issues. 
Behind the slogan ‘Treatment works’ lies a range of
difficult questions; many are rarely asked and most
produce no easy answers. According to the authors,
these questions demand evaluation of the way the
treatment agencies operate. By implication, they
introduce pertinent questions about the distribution
and location of services, and demand an
examination of current practices. This book sets out
to address some of these questions, including:
■ Which treatments work with what sorts of
abusers? 
■ What are the key indicators of likely success?
■ Does coercion work, or must treatment be
freely entered into?
■ Is drug testing an essential backup for
successful treatment?
Featuring contributions from some of the leading
figures in this field, this book will be of value to
students, academics and professionals studying
drug treatment in the areas of criminology, social
policy and medicine. Philip Bean is an Emeritus
Professor of Criminology and former director of the
Midland Centre for Criminology and Criminal
Justice at Loughborough University. Teresa Nemitz is
a researcher at Loughborough University.
Using women
Roberts M and Vromen N
DrugScope 2005, 71 pp.
The Using Women Campaign was developed by
DrugScope, the UK’s leading independent centre of
expertise on drugs and drug policy, and is
specifically concerned with women who get into
trouble because of illegal drugs. There was an
increase of 173 per cent in the average number of
females in custody in between 1992 and 2002. In
2002, 44 per cent of the adult female prison
population were in prison for drug offences. The
campaign believes that a substantial reduction in
the number of women in prison for drug and drug-
related offences is both desirable and achievable. 
The opening section of this report gives facts and
figures about women in prison in the UK. It outlines
some recent improvements in referral and
treatment processes for drug-using women and
suggests ways of dealing with the growth in the
female prison population. 
The remainder of the report examines the key issues
in detail – providing a platform for the voices of
ex-prisoners and professionals who have spoken to
Using Women. The next four chapters are
concerned with the link between drugs and crime,
the experiences of women in the prison system, the
impact on children and alternatives to prison. A
final chapter draws out the policy messages and
sets out a 12-step reform programme.
Report of the International Narcotics Control
Board for 2005 
United Nations 2006, 112 pp.
ISBN 92 1 148209 7 
As the International Narcotics Control Board
demonstrated in its annual report for 2004, the
fundamental interaction between the supply of and
demand for drugs is anything but straightforward.
The same applies to alternative development, which
the Board has chosen to examine in the first
chapter of its report for this year. The report
observes that there are substantial limitations in
alternative development approaches taken in the
past, and the concept needs to be broadened in
order to achieve large-scale, sustainable results. The
issue of legitimate alternative livelihoods needs
support in both rural and urban areas where illicit
drugs are abused, instead of addressing only rural
areas where illicit drug crops are cultivated.
The second and third chapters follow the format of
previous reports. Chapter II, Operation of the
international drug control system, describes the
current status of adherence to the Single
Convention of 1961 and levels of co-operation with
the control system by member States in relation to
narcotic drugs, psychotropic substances, precursors
and special topics. Chapter III, Analysis of the world
situation, covers the five continents in terms of
major developments; treaty adherence; regional
co-operation; national legislation, policy and action;
cultivation, production, manufacture, trafficking and
abuse; and missions from the Board to selected
countries.
A new chapter introduced in this 2005 report is
titled ‘Recommendations to Governments, the
United Nations and other relevant international and
regional organizations’. This chapter selects for
special emphasis some of the key recommendations
and proposals for further action contained in earlier
chapters. 
drugnet
IRELAND
28
Recent publications
low res
Journal articles
The following abstracts are from a selection of
articles relating to the drugs situation in Ireland
recently published in international journals.
Blood alcohol levels in persons who died from
accidents and suicide
Bedford D, O’Farrell A and Howell F
Irish Medical Journal 2006; 99(3): 80–83
This study reviewed coroners’ records to identify
blood alcohol concentrations of 129 persons who
died as a result of injury or suicide in three counties
in 2001 and 2002. Of these, 98 (76%) were male,
55 (43%) were road traffic accidents (RTAs), 31
(24%) were suicides, 12 (9%) misused substances,
11 (8.5%) were in house fires and 20 (15.5%) were
due to other causes. 
Of the 55 who died as a result of RTAs, 22 (40%)
had positive blood alcohol concentrations, ranging
from 16mg per 100ml to 325mg per 100ml. Of the
31 who died as a result of suicide, 28 (90%) were
male and blood alcohol concentrations were
available for 29 (94%) persons. Of these, 16 (56%)
had alcohol detected. Persons aged less than 30
years were more likely to have alcohol in their
blood (p<0.002). The mean blood alcohol
concentration for persons aged less than 30 was
192mg per 100ml, compared to 84mg per 100ml
for those aged 30 and over. The mean blood
alcohol concentration for adults who died in house
fires was 225mg per 100ml. Of the 12 who had a
record of substance misuse, 11 had blood alcohol
concentrations completed and six had a blood
alcohol level greater than 79mg per 100ml,
indicating a link between alcohol and drug use. The
high blood alcohol concentrations in those who
died as a result of suicide or injury reflect the high
level of alcohol consumption and binge drinking in
Ireland. 
Providing health education on accidental drug
overdose
Branagan O and Grogan L
Nursing Times 2006; 102(6): 32–3
There is an association between intravenous drug
use and increased risk of death due to overdose.
This article reports the results of an evaluation of a
health promotion programme to educate drug
users on how to prevent and how to deal with an
overdose. The health promotion intervention
consisted of a poster and leaflet. A convenience
sampling method was employed and 20% of
service users attending 15 drug treatment clinics
were asked to complete the questionnaire. In total,
200 questionnaires were distributed; 194 (97%)
were completed. Of the 194 respondents, 81% had
read the poster and 78% recalled a useful message
from the poster. Over 70% reported that they
changed the way they thought about or dealt with
an overdose. One-fifth of the respondents
suggested improvements to the poster and leaflet.
This nurse-led intervention had an important and
positive impact on service users.
Drug-related mortality and its impact on adult
mortality in eight European countries
Bargagli AM, Hickman M, Davoli M, Perucci CA,
Schifano P, Buster M, Brugal T and Vicente J
European Journal of Public Health 2006; 16(2):
198–202
The objective of this study was to estimate the
mortality rates from drug-related deaths and other
causes among problem drug users and population
attributable risk of death due to opiate use in eight
study sites in Europe. Opiate users were recruited
from drug treatment centres during the period
1990–1998 and deaths followed up through
national or local mortality registries. Gender-specific
overall mortality rate, proportion of deaths by cause
(drug-related, HIV, other), standardized mortality
ratios (SMRs), and the attributable risk fraction
(ARF) were estimated. Crude mortality rates varied
from 1 per 100 person-years in the Dublin and
London cohorts to 3.8 per 100 person-years in
Barcelona. The highest drug-related mortality rate
was 10 per 1000 person-years in Barcelona; the
rates were similar to 7 per 1000 person-years in
Denmark, London, Rome, and Vienna, and < 3.5
per 1000 person-years for the others cohorts. The
mortality rate for AIDS was < 2 per 1000
person-years in all the cohorts except Lisbon, Rome,
and Barcelona, for which it was similar to 6 per
1000 person-years. The highest SMR among males
was 21.1 in Barcelona, and among females the
highest SMRs were 53.7 and 37.7 in Barcelona and
Rome, respectively. In Denmark the ARF was 5%,
whereas it was > 10% in all other study sites and
24% in Barcelona. Cohort mortality studies,
especially in combination with estimates of
prevalence, provide useful insights into the impact
of opiate use on mortality across European
countries and emphasize how preventing overall
and drug-related deaths among opiate users can
significantly improve the health of the population.
Responses to positive and negative
smoking-related images: effects of current
smoking status and degree of smoking addiction
van Hanswijck de Jonge L and Gormley M
Addictive Behaviors 2005; 30(8): 1587–91
The literature indicates that stimulant users of
various dependency levels endorse and react
differently to stimuli that portray the stimulant
either positively or negatively; however, these
studies have not been extended to smoking. Here,
pictures are used to depict either positive or
negative connotations of smoking. The current
study concentrated on smokers with different levels
of dependency. Seventy-three digital images were
rated on both a smoking and emotional content
scale. The pictures were rank ordered, yielding the
10 most positive and negative smoking-related
pictures. Emotional content scores for these pictures
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were also recorded. Data from 148 subjects [light-
(n=28), heavy- (n=17), ex- (n=32) and
never-smokers (n=71)] were analysed. Using a
mixed factorial ANOVA light and heavy smokers
were found to score positive pictures significantly
more positive than the never-smokers, they did not
vary on negative or emotional ratings. Thus positive
pictures did not distinguish heavy and light levels of
substance use as suggested by the literature and
this was not influenced by emotional content.
Psychiatric morbidity in a cross-sectional sample
of male remanded prisoners 
Linehan SA, Duffy DM, Wright B, Curtin K, Monks S
and Kennedy HG
Irish Journal of Psychological Medicine 2005; 22(4):
128–132
The objective of this study was to estimate the
psychiatric service requirements of the remand
population. The authors interviewed 232 (42.6%)
men, a representative sample of men on remand,
using the SADS-L, SODQ and a structured
demographic interview. High rates of psychiatric
morbidity were found in the sample. The six-month
prevalence of psychosis was 7.6%, almost twice the
rate in a recent international meta-analysis. Major
depressive disorder was present in 10.1% (six
month prevalence). Substance misuse problems
were also common but there was no significant
difference between rates of substance misuse in
psychotic and non-psychotic prisoners. A total of
31.2% had a lifetime history of any mental illness
(excluding substance misuse, adjustment disorder
and personality disorder). The high levels of
psychiatric morbidity detected in the sample
indicate a substantial unmet need for mental health
services and addiction treatment services for the
mentally ill in Irish prisons. 
Psychiatric problems in children exposed to
opiates in utero
Clarke C and Fitzpatrick C
Irish Journal of Psychological Medicine 2005; 22(4):
121–123
The objective of this study was to describe the
psychosocial and clinical characteristics of children
referred to a community-based child and
adolescent mental health service, whose mothers
reported that they took opiates during the
pregnancy. In a retrospective study, the case notes
of all children whose mothers reported that they
had been exposed to opiates in utero, and who
were referred to the Department of Child and
Family Psychiatry, Mater Hospital, between 2001
and 2003, were identified by maternal reports.
Information was obtained on age, gender, referral
source, socio-economic group, family type, number
of siblings, involvement of community care services,
nature of presenting problems, diagnosis,
interventions offered, and treatment difficulties.
Information was recorded anonymously.
Fifteen children were identified, of whom nine were
male. Most were found to be living with their
mother alone or with their mother and a partner,
and to be socially and financially disadvantaged.
Their presenting complaints usually involved
combinations of aggressive, hyperactive, and
oppositional behaviour. Diagnoses included ADHD,
a speech and language disorder, and an axis II
disorder. Interventions were frequently unsuccessful
because of parents’ difficulties with attending
appointments and because of instability in the
families’ living arrangements. The authors conclude
that these children, due to a complex interplay of
biological and psychosocial adversity, are at serious
risk of ongoing psychiatric disorders in childhood
and adolescence and for adverse outcomes in adult
life. A prospective cohort study of all children born
to opiate-dependent mothers is necessary to
quantify the level of risk and identify resilience
factors.
The point-prevalence of alcohol use disorders
and binge drinking in an Irish general hospital
Molyneux GJ, Elizabeth C and Dooley E
Irish Journal of Psychological Medicine 2006; 23(1):
17–20
There is a paucity of data concerning the
prevalence of alcohol use disorders and binge
drinking in the general hospital adult population in
Ireland. The authors examined the point-prevalence
of alcohol use disorders and of binge drinking in
the adult inpatient population of the acute wards of
an Irish university teaching hospital. The secondary
aim was to examine gender, age, and patient group
(medical/surgical) as risk factors. The authors
administered the Alcohol Use Disorders
Identification Test (AUDIT) to all consenting patients
(n=126) on the acute adult medical and surgical
wards over one day.
76% of all inpatients on the acute medical and
surgical wards were interviewed (n=126) using the
AUDIT. Of the subjects, 28% screened positive for
an alcohol use disorder, of whom 91% were
identified as binge drinkers. A further 8% of the
subjects screened positive for binge drinking but
were not identified as having an alcohol use
disorder. Overall, 36% of the subjects screened
positive for either an alcohol use disorder and/or for
binge drinking using the AUDIT. Being male and
aged under 65 were risk factors for both alcohol use
disorders and binge drinking.
The high point-prevalences of alcohol use disorders
and binge drinking in hospital inpatients in
particular are a cause for concern as they may have
illness complicated by or secondary to undiagnosed
alcohol excess. As this population is an easily
accessible group for screening, and clinical and
economic evidence supports intervention, we
recommend screening all acute hospital admissions
for alcohol use disorders and binge drinking,
followed by appropriate management.
(Compiled by Joan Moore and Louise Farragher)
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June
28 June 2006
Treatment effectiveness: how to deliver
Venue: Mermaid Conference Centre, London
Organised by/Contact: National Treatment
Agency
www.nta.nhs.uk 
Information: The conference aims to provide
practical guidance, advice and best practice on
delivering treatment which improves adult clients'
journeys into, through and beyond treatment.
July
6–8 July 2006
The European Association of Addiction Therapy
(EAAT)
Venue: Central Hall Westminster, London
Organised by/Contact: EAAT Scientific Secretariat
Tel: +44 (0)115 969 2016 
Fax: +44 (0)115 969 2017
www.eaat.org 
Information: The European Association of
Addiction Therapies (EAAT) provides a focus for
understanding the scientific and social bases of
addiction and discusses relevant therapies
throughout Europe. Through the annual
conference, working with the journal European
Addiction Research, and international collaborative
ventures, the EAAT aims to improve the
understanding, treatment and management of
addictive behaviours. The conference topics and
sessions are as follows: 
Session 1: Genetics, Aetiology, Epidemiology,
Neuroimaging and Underlying Neuronal
Mechanisms 
Session 2: Treating the clinical consequences 1:
Alcoholism 
Session 3: Treating the clinical consequences 2:
Drug dependence 
Session 4: Nicotine, society and the accepted
addictions 
Session 5: Dual diagnosis
Session 6: Late breaking news, Case studies, Culture
and history
September
3–7 September 2006
What makes good practice—49th International
Council on Alcohol and Addictions (ICAA)
Conference on Dependencies
Venue: Assembly Hall, Edinburgh
Organised by/Contact: International Council on
Alcohol and Addictions
www.icaa-uk.org 
Information: The conference will provide a broad
platform of dialogue and enlightenment for
professionals in the fields of substance-abuse
prevention, treatment, research and policymaking.
In a multidisciplinary setting, experiences on the
grassroots level will encounter latest research
findings and tie the many strands together. It will
also feature professional visits and special-interest
seminars on 8 September 2006. Local and
International Organising Committees have started
planning ICAA’s major event of 2006, which will
allow a comprehensive approach representing
opinions of various fields in different forms of
sharing knowledge – while still exploring
commonalitites for future building of plans.
18 September 2006
The Drug Treatment Centre Board 2006 Autumn
Educational Seminars
Venue: Newgrange Hotel, Navan, Co Meath
Organised by/Contact: Drug Treatment Centre
Board
Tel: + 353 (01) 6488600
www.addictionireland.ie/events
Information: Following on from the success of the
2005 Educational Events in Galway, Limerick and
Cork, The Drug Treatment Centre Board will
present a series of seminars in Meath, Donegal and
Kilkenny. With a range of speakers including Dr
Brion Sweeney, Dr Bobby Smyth, Dr Joe Barry, Dr
Declan Bedford and Dr Des Corrigan, the
programme will address issues such as the 4 Tier
Model, Development of Adolescent Services, Drugs
and Alcohol and the Effects of Psychoactive Drugs.
Mindful of the opinions of delegates at previous
events, we have included in the programme a
workshop component that will present case studies
and design care plans in a multidisciplinary
manner. This one-day seminar costs 140.00 per
person, with a 10% discount for parties of three or
more booking together. The cost includes copies of
the speakers’ papers, refreshments and lunch. 
October
4 October
The Drug Treatment Centre Board 2006 Autumn
Educational Seminars
Venue: Mill Park Hotel, Donegal Town, Co Donegal
Organised by/Contact: Drug Treatment Centre
Board
Tel: + 353 (01) 6488600
www.addictionireland.ie/events
12–13 October 2006
National Conference on Injecting Drug Use
Venue: Lord’s Cricket Ground, London
Organised by/Contact: Exchange Supplies 
Tel: +44 (0)1305 262244
www.exchangesupplies.org 
Information: The full programme will contain over
30 plenary and parallel sessions designed to inform
practice, explore policy and develop skills.
Key conference themes:
■ 20 years of needle exchange: evaluating
progress, identifying priorities
drugnet
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■ prisons: viral transmission and needle
exchange
■ femoral injecting
■ snowballing and non-opiate injecting
■ HIV – what do the figures mean?
■ hepatitis C
■ wound care
Call for papers: Papers and ideas for
presentations are welcomed. Submissions
may be accepted for either oral paper
presentations or poster displays. All
submissions will be peer reviewed and
judged on their relevance to the
conference. The deadline for submissions is
1 August 2006.
17 October 2006
The Drug Treatment Centre Board 2006
Autumn Educational Seminars
Venue: Kilkenny River Court, Kilkenny
Organised by/Contact: Drug Treatment
Centre Board
Tel: + 353 (01) 6488600
www.addictionireland.ie/events
November
7 November 2006
Hepatitis C: Action for prevention,
treatment and management
Venue: Royal College of Surgeons, London
Organised by/Conatct: KCA, 43a Windmill
STreet, Gravesend, Kent DA12 1BA, UK. 
Tel: +44 (0)1474 326168
Fax: +44 (0)1474 325049
Email: tcw@kca.org.uk 
Information: This conference presents an
action plan for agencies and professionals
who work with drug users. Topics covered
include: interventions in tackling hepatitis C,
improving drug treatment outcomes and
retention rates, inform effective
commissioning of drug services to deal with
hepatitis C and demonstrate the
effectiveness for user involvement.
Conference booking fee: Sterling £195
8 November 2006
Drug & Alcohol Professionals Conference
2006
Venue: Royal Institute of British Architects,
66 Portland Place, London
Organised by/contact: The Federation of
Drug & Alcohol Professionals (FDAP) in
association with Drink & Drugs News 
www.fdap.org.uk 
Information: FDAP’s Annual Drug and
Alcohol Professionals conference aims to
help support the development of front line
workers, managers and commissioners, and
to give delegates the opportunity to have
their say on important issues of the day.
This year’s event will include plenary
presentations on the future of alcohol
services, residential rehab and harm
reduction, as well as the next steps on
workforce development. Practically-focused
workshops and seminars will cover a range
of issues, such as: services for steroid users;
meeting the needs of young people;
working with clients with co-occurring
gambling problems; brief therapies for
alcohol problems; and, managing child
protection issues. And delegates will have
the chance to contribute to policy debates
on: whether psychological therapies work
with substance users; what role, if any, there
should be for coercive treatment; and
whether practitioners should have to be
qualified to work in this field. Conference
booking fee: FDAP Members–Sterling £110
Others–Sterling £140
16-17 November 2006
International Child Psychiatry Conference
on the Treatment of Adolescent
Addiction
Venue: The Davenport Hotel, Merrion
Square, Dublin 2
Organised by/Contact: Drug Treatment
Centre Board
Tel: + 353 (01) 6488600
www.addictionireland.ie/events
Information: The Drug Treatment Centre
Board has designed a two-day Conference
to take place in November 2006 with the
main learning objective being to equip
attendees with the basic skills to conduct
assessments of complex adolescent
addiction cases and to develop treatment
plans to tackle the problems identified. The
format of the Conference will involve a
combination of lectures, case discussions,
small-group work and workshops dealing
with very specific area of treatment. Key
team members from the DTCB Young
Persons’ Programme, including Dr Gerry
McCarney and Dr Bobby Smyth, will deliver
this conference, with special guest speaker
Dr KAH Mirza. Cost is €295.00 per
delegate, with a 10% reduction for groups
of three or more from the same
organisation. Places are limited.
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The Drug Misuse Research Division
(DMRD) of the Health Research
Board is a multi-disciplinary team of
researchers and information
specialists who provide objective,
reliable and comparable information
on the drug situation, its
consequences and responses in
Ireland. The DMRD maintains two
national drug-related surveillance
systems and is the national focal
point for the European Monitoring
Centre for Drugs and Drug
Addiction. The division also
manages the National
Documentation Centre on Drug Use.
The DMRD disseminates research
findings, information and news
through its quarterly newsletter,
Drugnet Ireland, and other
publications. Through its activities,
the DMRD aims to inform policy
and practice in relation to drug use.
Drugnet Ireland mailing list
If you wish to have your name
included on the mailing list for
future issues of Drugnet Ireland,
please send your contact details to
Charlene Lydon,
Drug Misuse Research Division,
Health Research Board,
Knockmaun House,
42–47 Lower Mount Street,
Dublin 2.
Tel: 01 676 1176 ext 127;
Email: dmrd@hrb.ie
Please indicate whether you would
also like to be included on the
mailing list for Drugnet Europe and
Drugs in focus.
The documents referred to in this
issue of Drugnet Ireland are available
in the National Documentation
Centre on Drug Use at the above
address. Tel: 676 1176 ext 175;
Email ndc@hrb.ie
